var title_f39_49_40720="Cystoscope camera light source";
var content_f39_49_40720=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F83018&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F83018&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Cystoscope camera and light source",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 421px; height: 334px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Cystocope (A) camera and (B) light cord.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_49_40720=[""].join("\n");
var outline_f39_49_40720=null;
var title_f39_49_40721="Tongue reconstruct STSG";
var content_f39_49_40721=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F82465&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F82465&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Tongue after reconstruction with split-thickness skin graft (STSG)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 297px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Neil D Gross, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_49_40721=[""].join("\n");
var outline_f39_49_40721=null;
var title_f39_49_40722="Laparoscopic Heller myotomy with Toupet fundoplication";
var content_f39_49_40722=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F72012&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F72012&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Laparoscopic Heller myotomy with Toupet fundoplication",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This is an intraopertive photograph showing the edge of the Toupet fundoplication sutures to the edge of the myotomy. The procedure was performed laparoscopically.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_49_40722=[""].join("\n");
var outline_f39_49_40722=null;
var title_f39_49_40723="Left median (middle or septal) fascicular block";
var content_f39_49_40723=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"39\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Left median (middle or septal) fascicular block",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/49/40723/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/49/40723/contributors\">",
"     William H Sauer, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/49/40723/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/49/40723/contributors\">",
"     Ary L Goldberger, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/49/40723/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/49/40723/contributors\">",
"     Gordon M Saperia, MD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?39/49/40723/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 24, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the discussion that follows, it is assumed that the reader understands the general concepts of cardiac vectors, asynchronous activation of the ventricles (delayed as in fascicular or bundle branch block, or early as in preexcitation), and the effects that asynchrony has on the duration, morphology and amplitude of the QRS complex. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/4/9283?source=see_link\">",
"     \"ECG tutorial: Physiology of the conduction system\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/61/13271?source=see_link\">",
"     \"General principles of asynchronous activation and preexcitation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     FASCICLES OF THE LEFT BUNDLE BRANCH",
"    </span>",
"    &nbsp;&mdash;&nbsp;The classic hypothesis proposed by Rosenbaum and his coworkers was that the left bundle branch divides into two fascicles of rapidly conducting Purkinje fibers (ie, phase 0 dependent on the rapid inward sodium current) (",
"    <a class=\"graphic graphic_figure graphicRef63340 \" href=\"mobipreview.htm?42/52/43841\">",
"     figure 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40723/abstract/1\">",
"     1",
"    </a>",
"    ]. These fascicles primarily affect the",
"    <strong>",
"     direction",
"    </strong>",
"    of depolarization:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The left anterior fascicle crosses the left ventricular outflow tract and terminates in the Purkinje system of the anterolateral wall of the left ventricle.",
"     </li>",
"     <li>",
"      The left posterior fascicle appears as an extension of the main bundle and fans out extensively posteriorly toward the papillary muscle and inferoposteriorly to the free wall of the left ventricle.",
"     </li>",
"     <li>",
"      In addition, a third fascicle, called the left septal, middle, or median fascicle, is found in nearly 65 percent of people [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/49/40723/abstract/2,3\">",
"       2,3",
"      </a>",
"      ]. This fascicle runs to the interventricular septum, and can arise from the common left bundle or from the anterior, posterior or both fascicles.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Support for the trifascicular nature of the left bundle comes from the observations in animals and humans that depolarization of the left ventricle begins in three areas corresponding to the terminal portions of the anterior, posterior and septal fascicles [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40723/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. In the normal heart, the three fascicles of the left bundle are simultaneously depolarized.",
"   </p>",
"   <p>",
"    There is significant variability in the size and distribution of the left fascicles. The left bundle may initially branch into two or three initial branches, but these branches further fan out and intersect with each other. This is the basis for fascicular ventricular tachycardia. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/14/26858?source=see_link\">",
"     \"Monomorphic ventricular tachycardia in the absence of apparent structural heart disease\"",
"    </a>",
"    .) In dissections of twenty consecutive cadaveric hearts, there was no discrete pattern of left ventricular fascicle distribution noted [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40723/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The anatomy of the median fascicle, when found, is more variable than the other fascicles and have a large number of interconnections [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40723/abstract/2,6\">",
"     2,6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Blood supply",
"    </span>",
"    &nbsp;&mdash;&nbsp;The left anterior and median fascicles are supplied either by septal branches of the left anterior descending artery or by the AV nodal artery (",
"    <a class=\"graphic graphic_figure graphicRef70956 \" href=\"mobipreview.htm?21/44/22213\">",
"     figure 2",
"    </a>",
"    ). The proximal part of the left posterior fascicle is supplied by the artery to the AV node and, at times, by septal branches of the left anterior descending (LAD) artery. The distal portion has a dual blood supply from both anterior and posterior septal perforating arteries.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     ELECTROCARDIOGRAM IN LEFT MEDIAN FASCICULAR BLOCK",
"    </span>",
"    &nbsp;&mdash;&nbsp;Myocardial activation may be affected in two ways by a conduction disturbance in the left median fascicle: apparent loss or gain of anterior forces. In fact, the demonstration of these changes was one of the early observations suggesting the existence of a left median fascicle. The electrocardiographic pattern seen with left median fascicular block (LMFB) is probably determined by the differences in the sites of insertion of the median, anterior, and posterior fascicles:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Apparent loss of anterior forces &mdash; Functional or hyperkalemia-induced dysfunction in the left median fascicle can lead to the loss of anterior forces, resulting in the transient development of q waves in leads V1 and V2, which normally have a positive initial deflection due to septal depolarization [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/49/40723/abstract/7,8\">",
"       7,8",
"      </a>",
"      ]. Similar changes occur with permanent LMFB and are indistinguishable from septal fibrosis or infarction.",
"     </li>",
"     <li>",
"      Apparent gain of anterior forces &mdash; In marked contrast, prominent R waves are seen in the right precordial leads when LMFB leads to a gain of anterior forces [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/49/40723/abstract/9,10\">",
"       9,10",
"      </a>",
"      ]. These changes are similar to those that occur in true posterior (dorsal) myocardial infarction (MI). The prominence of the R waves may be increased when LMFB occurs in association with right bundle branch block.",
"     </li>",
"     <li>",
"      Counterclockwise rotation (CCWR) &mdash; The relationship between shift of the transitional zone on the standard 12-lead ECG and anatomical rotation of the heart in one plane was studied by cardiac computed tomography (CT) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/49/40723/abstract/11\">",
"       11",
"      </a>",
"      ]. The left-sided angle between the interventricular septum and horizontal axis of the body (the septal angle) was determined on the cardiac CT. The mechanism of CCWR could be attributed to the septal angle in about two-thirds of the cases, but the remainder was thought due to left septal fascicular block.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11522767\">",
"    <span class=\"h2\">",
"     Definition",
"    </span>",
"    &nbsp;&mdash;&nbsp;A task force from the American Heart Association, the American College of Cardiology, and the Heart Rhythm Society has defined the electrocardiographic features of left anterior and posterior fascicular block. In this document, there is an acknowledgment of the lack of universally accepted criteria for left median fascicular block, and therefore this condition was not electrocardiographically defined by this group [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40723/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     CLINICAL IMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;In a review of some 26,000 electrocardiograms, criteria for left septal or median fascicular block were found in about 0.5 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40723/abstract/13\">",
"     13",
"    </a>",
"    ]. The major clinical implication of LMFB is that the ECG mimics the changes induced by a septal or posterior MI. LMFB can be induced by ischemia, fibrosis, or sclero-degenerative changes, which are generally associated with similar alterations in the other fascicles [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40723/abstract/2,3,9\">",
"     2,3,9",
"    </a>",
"    ]. A variety of underlying disorders may be responsible, including ischemic or hypertensive heart disease, hypertrophic cardiomyopathy, and diabetes mellitus. Of interest, canine studies suggest that incomplete LBBB may be a form of left septal fascicular block [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40723/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are no symptoms induced by an isolated block in one of the left bundle fascicles. Therapy should be considered only in patients with persistent bifascicular or trifascicular block. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/62/12261?source=see_link\">",
"     \"Course and treatment of chronic bifascicular block\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <strong>",
"     Neuromuscular diseases",
"    </strong>",
"    &mdash; A number of neuromuscular diseases are associated with fascicular block. These include myotonic muscular dystrophy, Kearns-Sayre syndrome, Erb's dystrophy (limb-girdle), and peroneal muscular atrophy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/20/1351?source=see_link\">",
"     \"Inherited syndromes associated with cardiac disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    These patients represent a special class and are treated more aggressively with pacemakers due to the potential for unpredictably rapid progression of conduction disease. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/52/27463?source=see_link&amp;anchor=H23#H23\">",
"     \"Indications for permanent cardiac pacing\", section on 'Neuromuscular diseases'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H78157060\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The bundle of His divides into left anterior and right posterior fascicles, and in about 65 percent of cases, into a third fascicle, called the left septal or median fascicle. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Fascicles of the left bundle branch'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      However, there is no uniformly accepted definition of left median (middle or septal) fascicular block. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Electrocardiogram in left median fascicular block'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      There are no symptoms induced by an isolated block in one of the left bundle fascicles. Therapy should be considered only in patients with persistent bifascicular or trifascicular block.",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Rosenbaum M, Elizari MV, Lazzari JO. The Hemiblocks, Tampa Tracings, Tampa 1970.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40723/abstract/2\">",
"      Demoulin JC, Kulbertus HE. Histopathological examination of concept of left hemiblock. Br Heart J 1972; 34:807.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40723/abstract/3\">",
"      Uhley HN. Some controversy regarding the peripheral distribution of the conduction system. Am J Cardiol 1972; 30:919.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40723/abstract/4\">",
"      Myerburg RJ, Nilsson K, Gelband H. Physiology of canine intraventricular conduction and endocardial excitation. Circ Res 1972; 30:217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40723/abstract/5\">",
"      Durrer D, van Dam RT, Freud GE, et al. Total excitation of the isolated human heart. Circulation 1970; 41:899.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40723/abstract/6\">",
"      Massing GK, James TN. Anatomical configuration of the His bundle and bundle branches in the human heart. Circulation 1976; 53:609.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40723/abstract/7\">",
"      Gambetta M, Childers RW. Rate-dependent right precordial Q waves: \"septal focal block\". Am J Cardiol 1973; 32:196.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40723/abstract/8\">",
"      Arnsdorf MF. Electrocardiogram in Hyperkalemia: electrocardiographic pattern of anteroseptal myocardial infarction mimicked by hyperkalemia-induced disturbance of impulse conduction. Arch Intern Med 1976; 136:1161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40723/abstract/9\">",
"      Nakaya Y, Hiasa Y, Murayama Y, et al. Prominent anterior QRS force as a manifestation of left septal fascicular block. J Electrocardiol 1978; 11:39.",
"     </a>",
"    </li>",
"    <li>",
"     DePadua FI, Pereirnha A, Lopes MG. Conduction defects. In: Comprehensive Electrocardiography: Theory and Practice in Health and Disease, MacFarlane P, Veitch Lawrie TD (Eds), Pergamon Press, New York 1989. p.459.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40723/abstract/11\">",
"      Tahara Y, Mizuno H, Ono A, Ishikawa K. Evaluation of the electrocardiographic transitional zone by cardiac computed tomography. J Electrocardiol 1991; 24:239.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40723/abstract/12\">",
"      Surawicz B, Childers R, Deal BJ, et al. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part III: intraventricular conduction disturbances: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Endorsed by the International Society for Computerized Electrocardiology. J Am Coll Cardiol 2009; 53:976.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40723/abstract/13\">",
"      MacAlpin RN. In search of left septal fascicular block. Am Heart J 2002; 144:948.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40723/abstract/14\">",
"      Dabrowska B, Ruka M, Walczak E. The electrocardiographic diagnosis of left septal fascicular block. Eur J Cardiol 1978; 6:347.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2111 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-202.43.93.2-04D01F2D42-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_49_40723=[""].join("\n");
var outline_f39_49_40723=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H78157060\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      FASCICLES OF THE LEFT BUNDLE BRANCH",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Blood supply",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      ELECTROCARDIOGRAM IN LEFT MEDIAN FASCICULAR BLOCK",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11522767\">",
"      Definition",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      CLINICAL IMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H78157060\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/2111\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/2111|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?42/52/43841\" title=\"figure 1\">",
"      Normal conduction system",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?21/44/22213\" title=\"figure 2\">",
"      Coronary artery anatomy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/62/12261?source=related_link\">",
"      Course and treatment of chronic bifascicular block",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/4/9283?source=related_link\">",
"      ECG tutorial: Physiology of the conduction system",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/61/13271?source=related_link\">",
"      General principles of asynchronous activation and preexcitation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/52/27463?source=related_link\">",
"      Indications for permanent cardiac pacing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/20/1351?source=related_link\">",
"      Inherited syndromes associated with cardiac disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/14/26858?source=related_link\">",
"      Monomorphic ventricular tachycardia in the absence of apparent structural heart disease",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f39_49_40724="Langerhans cell histiocytosis scalp lesions";
var content_f39_49_40724=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F68224&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F68224&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Langerhans cell histiocytosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Erythematous macules, crusts, erosions, and petechiae are present on the scalp of this infant.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_49_40724=[""].join("\n");
var outline_f39_49_40724=null;
var title_f39_49_40725="Fracture of thumb metacarpal base Bennetts";
var content_f39_49_40725=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F72289%7EEM%2F50297%7EEM%2F63101&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F72289%7EEM%2F50297%7EEM%2F63101&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Fracture of thumb metacarpal base: Type I (Bennett's)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 442px; height: 331px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Each of these anteroposterior radiographs shows an intra-articular fracture of the thumb metacarpal. The Type I or \"Bennett's\" fracture of the proximal 1st metacarpal illustrated here is characterized by its articular involvement and the persistent attachment of the volar fragment to the trapezium.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Kevin Burroughs, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Extraarticular fracture of the first metacarpal",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 264px; height: 360px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This anteroposterior radiograph shows a type III fracture of the proximal 1st metacarpal with characteristic sparing of the articular surface. Significant shortening of the metacarpal is also apparent in this view.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Kevin Burroughs, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Nondisplaced thumb metacarpal fracture",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 270px; height: 360px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    In this radiograph a nondisplaced fracture of the&nbsp;thumb metacarpal distal to the carpal metacarpal joint is seen. This is a nondisplaced type III fracture of the first metacarpal.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Kevin Burroughs, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_49_40725=[""].join("\n");
var outline_f39_49_40725=null;
var title_f39_49_40726="Complete nail plate avulsion";
var content_f39_49_40726=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F86405%7EDERM%2F86421&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F86405%7EDERM%2F86421&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Complete nail plate avulsion",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 379px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Nail plate replacement after nail bed surgery",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 378px; height: 504px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Whenever possible, the nail plate is put back in place after nail bed biopsy to protect the wound and act as a biologic dressing. The nail plate can be taped or sutured in place.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_49_40726=[""].join("\n");
var outline_f39_49_40726=null;
var title_f39_49_40727="Clobazam: Drug information";
var content_f39_49_40727=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Clobazam: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?40/60/41924?source=see_link\">",
"    see \"Clobazam: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?32/4/32839?source=see_link\">",
"    see \"Clobazam: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F13688779\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Onfi&trade;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F152592\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Apo-Clobazam&reg;;",
"     </li>",
"     <li>",
"      Clobazam-10;",
"     </li>",
"     <li>",
"      Dom-Clobazam;",
"     </li>",
"     <li>",
"      Frisium&reg;;",
"     </li>",
"     <li>",
"      Novo-Clobazam;",
"     </li>",
"     <li>",
"      PMS-Clobazam",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F152632\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Benzodiazepine",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F152596\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Lennox-Gastaut (adjunctive):",
"     </b>",
"     U.S. labeling: Oral:",
"     <b>",
"      Note:",
"     </b>",
"     Dose should be titrated according to patient tolerability and response.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &le;30 kg: Initial: 5 mg once daily for &ge;1 week, then increase to 5 mg twice daily for &ge;1 week, then increase to 10 mg twice daily thereafter",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &gt;30 kg: Initial: 5 mg twice daily for &ge;1 week, then increase to 10 mg twice daily for &ge;1 week, then increase to 20 mg twice daily thereafter",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      CYP2C19 poor metabolizers:",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     &le;30 kg: Initial: 5 mg once daily for &ge;2 weeks, then increase to 5 mg twice daily; after &ge;1 week may increase to 10 mg twice daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     &gt;30 kg: Initial: 5 mg once daily for &ge;1 week, then increase to 5 mg twice daily for &ge;1 week, then increase to 10 mg twice daily; after &ge;1 week may increase to 20 mg twice daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Epilepsy (adjunctive):",
"     </b>",
"     Canadian labeling (not in U.S. labeling): Oral: Initial: 5-15 mg/day; dosage may be gradually adjusted (based on tolerance and seizure control) to a maximum of 80 mg/day.",
"     <b>",
"      Note:",
"     </b>",
"     Daily doses of up to 30 mg may be taken as a single dose at bedtime; higher doses should be divided.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Catamenial epilepsy (unlabeled use):",
"     </b>",
"     Oral: 20-30 mg daily for 10 days during the perimenstrual period (Feely, 1984)",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F152612\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?32/4/32839?source=see_link\">",
"      see \"Clobazam: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Lennox-Gastaut (adjunctive):",
"     </b>",
"     U.S. labeling: Children &ge;2 years: Refer to adult dosing.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Epilepsy (adjunctive):",
"     </b>",
"     Canadian labeling (not in U.S. labeling): Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children &lt;2 years: Initial 0.5-1 mg/kg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children 2-16 years: Initial: 5 mg/day; may be increased (no more frequently than every 5 days) to a maximum of 40 mg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Epilepsy (monotherapy) (unlabeled use):",
"     </b>",
"     Children 2-16 years: Oral: Initial: Titrate slowly over 1-3 weeks to target dose of ~0.5 mg/kg/day in 2 divided doses (Canadian Study Group, 1998)",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F152597\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     <b>",
"      Lennox-Gastaut (adjunctive):",
"     </b>",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &le;30 kg: Initial: 5 mg once daily for &ge;2 weeks, then increase to 5 mg twice daily; after &ge;1 week may increase to 10 mg twice daily based on patient tolerability and response",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &gt;30 kg: Initial: 5 mg once daily for &ge;1 week, then increase to 5 mg twice daily for &ge;1 week, then increase to 10 mg twice daily; after &ge;1 week may increase to 20 mg twice daily based on patient tolerability and response",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F13689324\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     U.S. labeling:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &ge;30 mL/minute: No dosage adjustment necessary.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;30 mL/minute: No dosage adjustment provided in manufacturer&rsquo;s labeling (has not been studied); use with caution.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     Canadian labeling: No dosage adjustment provided in manufacturer&rsquo;s labeling; however, a reduced dosage is recommended.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F152598\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     U.S. labeling:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Mild-to-moderate impairment:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;margin-top:0em;text-align:justify;\">",
"     &le;30 kg: Initial: 5 mg once daily for &ge;2 weeks, then increase to 5 mg twice daily; after &ge;1 week may increase to 10 mg twice daily based on patient tolerability and response",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;margin-top:0em;text-align:justify;\">",
"     &gt;30 kg: Initial: 5 mg once daily for &ge;1 week, then increase to 5 mg twice daily for &ge;1 week, then increase to 10 mg twice daily; after &ge;1 week may increase to 20 mg twice daily based on patient tolerability and response",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Severe impairment: No dosage adjustment provided in manufacturer&rsquo;s labeling (has not been studied). Use with caution; undergoes extensive hepatic metabolism.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     Canadian labeling:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Mild-to-moderate impairment: No dosage adjustment provided in manufacturer&rsquo;s labeling; however, a reduced dosage is recommended.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Severe impairment: Use is contraindicated.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F13688780\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Onfi&trade;: 5 mg, 10 mg, 20 mg",
"    </p>",
"   </div>",
"   <div class=\"block foccan drugH1Div\" id=\"F10076209\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: Canada",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tablet:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Alti-Clobazam, Apo-Clobazam&reg;, Clobazam-10, Dom-Clobazam, Frisium&reg;, Novo-Clobazam, PMS-Clobazam, ratio-Clobazam: 10 mg",
"    </p>",
"   </div>",
"   <div class=\"block prod-avail drugH1Div\" id=\"F15859539\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Product Availability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Onfi&trade; oral suspension: FDA approved December 2012; anticipated availability is midyear to third quarter 2013.",
"    </p>",
"   </div>",
"   <div class=\"block csi drugH1Div\" id=\"F13689303\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Controlled Substance",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C-IV",
"    </p>",
"   </div>",
"   <div class=\"block meg drugH1Div\" id=\"F13362239\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Guide",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     An FDA-approved patient medication guide, which is available with the product information and at",
"     <a href=\"file://www.fda.gov/downloads/Drugs/DrugSafety/UCM277791.pdf\" target=\"_blank\">",
"      file://www.fda.gov/downloads/Drugs/DrugSafety/UCM277791.pdf",
"     </a>",
"     , must be dispensed with this medication.",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F152570\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     May be administered with or without food. Tablets can be crushed and mixed in applesauce.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F152569\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adjunctive treatment of seizures associated with Lennox-Gastaut syndrome",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Canadian labeling: Adjunctive treatment of epilepsy",
"    </p>",
"   </div>",
"   <div class=\"block usu drugH1Div\" id=\"F152629\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use - Unlabeled",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Catamenial epilepsy; epilepsy (monotherapy)",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F13689302\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       CloBAZam may be confused with clonazePAM",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F152630\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     &gt;10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Central nervous system: Somnolence (22%), fever (13%), lethargy (10%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Respiratory: Upper respiratory tract infection (12%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Central nervous system: Aggressiveness (8%), irritability (7%), ataxia (5%), fatigue (5%), insomnia (5%), sedation (5%), psychomotor hyperactivity (4%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Gastrointestinal: Salivation increased (9%), vomiting (7%), constipation (5%), appetite increased (3%), dysphagia (2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Genitourinary: Urinary tract infection (4%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Neuromuscular &amp; skeletal: Dysarthria (3%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Respiratory: Cough (5%), pneumonia (4%), bronchitis (2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Postmarketing and/or case reports (Limited to important or life-threatening): Aspiration, behavior changes, blurred vision, confusion, delirium, delusions, depression, diplopia, eosinophilia, hallucinations, leukopenia, mood changes, respiratory depression, Stevens-Johnson syndrome, suicidal ideation, suicide attempts, thrombocytopenia, toxic epidermal necrolysis",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F152573\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no contraindications in the manufacturer&rsquo;s labeling.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Canadian labeling (not in U.S. labeling): Hypersensitivity to clobazam or any component of the formulation (cross sensitivity with other benzodiazepines may exist); myasthenia gravis; narrow-angle glaucoma; severe hepatic or respiratory disease; sleep apnea; history of substance abuse; use in the first trimester of pregnancy; breast-feeding",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F152558\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Anterograde amnesia: Benzodiazepines have been associated with anterograde amnesia.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; CNS depression: May cause CNS depression, which may impair physical or mental abilities; patients must be cautioned about performing tasks which require mental alertness (eg, operating machinery or driving).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Paradoxical reactions: Paradoxical reactions, including hyperactive or aggressive behavior, have been reported with benzodiazepines, particularly in adolescent/pediatric or psychiatric patients.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Suicidal ideation: Pooled analysis of trials involving various antiepileptics (regardless of indication) showed an increased risk of suicidal thoughts/behavior (incidence rate: 0.43% treated patients compared to 0.24% of patients receiving placebo); risk observed as early as 1 week after initiation and continued through duration of trials (most trials &le;24 weeks). Monitor all patients for notable changes in behavior that might indicate suicidal thoughts or depression; notify healthcare provider immediately if symptoms occur.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Drug abuse: Use with caution in patients with a history of drug abuse or acute alcoholism; potential for drug dependency exists. Tolerance, psychological and physical dependence may occur with prolonged use.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatic impairment: Use with caution in patients with hepatic impairment; dose adjustment may be necessary.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Impaired gag reflex: Use with caution in patients with an impaired gag reflex.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Muscle weakness/coordination: Use with caution in patients with pre-existing muscle weakness or ataxia; may cause muscle weakness. The Canadian labeling contraindicates use in myasthenia gravis.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Psychiatric disease: Where possible, avoid use in patients with psychiatric disease (eg, depression, psychosis).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Respiratory disease: Use with caution in patients with respiratory disease. The Canadian labeling contraindicates use in severe respiratory insufficiency or sleep apnea syndrome.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; CNS depressants/psychoactive medications: Use with caution in patients receiving other CNS depressants or psychoactive medication; effects with other sedative drugs or ethanol may be potentiated.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Debilitated patients: Use with caution in debilitated patients.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Fall risk: Use with extreme caution in elderly and other patients at risk of falls; benzodiazepines have been associated with falls and traumatic injury.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Appropriate use: Does not have analgesic, antidepressant, or antipsychotic properties.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Chronic use: Tolerance and loss of seizure control have been reported with chronic administration.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Withdrawal: Rebound or withdrawal symptoms may occur following abrupt discontinuation or large decreases in dose. Use caution when reducing dose or withdrawing therapy; decrease slowly (eg, decrease weekly by 5-10 mg/day) and monitor for withdrawal symptoms. Flumazenil may cause withdrawal in patients receiving long-term benzodiazepine therapy.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F152626\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Substrate",
"     </b>",
"     of CYP2B6 (minor), CYP2C19 (major), CYP3A4 (minor), P-glycoprotein;",
"     <b>",
"      Note:",
"     </b>",
"     Assignment of Major/Minor substrate status based on clinically relevant drug interaction potential;",
"     <b>",
"      Inhibits",
"     </b>",
"     CYP2C9 (weak), CYP2D6 (moderate), UGT1A4, UGT1A6, UGT2B4;",
"     <b>",
"      Induces",
"     </b>",
"     CYP3A4 (weak/moderate)",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F152562\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alcohol (Ethyl): May enhance the CNS depressant effect of CloBAZam. Alcohol (Ethyl) may increase the serum concentration of CloBAZam.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antifungal Agents (Azole Derivatives, Systemic): May decrease the metabolism of Benzodiazepines (metabolized by oxidation). Management: The following combinations are specifically contraindicated: itraconazole with alprazolam, estazolam, oral midazolam, or triazolam; ketoconazole with alprazolam, estazolam, or triazolam.  Consider initial dose reductions of other benzodiazepines.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aprepitant: May increase the serum concentration of Benzodiazepines (metabolized by oxidation).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ARIPiprazole: CYP3A4 Inducers may decrease the serum concentration of ARIPiprazole.  Management: Double the oral aripiprazole dose and closely monitor clinical response.  Reduce the oral aripiprazole dose to 10-15 mg/day if the inducer is discontinued. Avoid use of CYP3A4 inducers for more than 14 days with extended-release injectable aripiprazole.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ARIPiprazole: CYP2D6 Inhibitors (Moderate) may increase the serum concentration of ARIPiprazole.  Management: Monitor for increased aripiprazole pharmacologic effects. Aripiprazole dose adjustments may or may not be required based on concomitant therapy and/or indication. Consult full interaction monograph for specific recommendations.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Axitinib: CYP3A4 Inducers (Weakly to Moderately Effective) may decrease the serum concentration of Axitinib.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Azelastine (Nasal): CNS Depressants may enhance the CNS depressant effect of Azelastine (Nasal).",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Buprenorphine: CNS Depressants may enhance the CNS depressant effect of Buprenorphine.  Management: Consider reduced doses of CNS depressants used in combination with buprenorphine.  Consider avoiding other CNS depressants in patients thought to be at high risk of buprenorphine overuse or self-injection.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Calcium Channel Blockers (Nondihydropyridine): May decrease the metabolism of Benzodiazepines (metabolized by oxidation).",
"     <b>",
"      Exceptions:",
"     </b>",
"     Bepridil [Off Market].",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CarBAMazepine: May increase the metabolism of Benzodiazepines (metabolized by oxidation).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cimetidine: May decrease the metabolism of Benzodiazepines (metabolized by oxidation).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CloZAPine: Benzodiazepines may enhance the adverse/toxic effect of CloZAPine.  Management: Consider decreasing the dose of (or possibly discontinuing) benzodiazepines prior to initiating clozapine.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CNS Depressants: May enhance the adverse/toxic effect of other CNS Depressants.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levocabastine (Nasal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Codeine: CYP2D6 Inhibitors (Moderate) may diminish the therapeutic effect of Codeine. These CYP2D6 inhibitors may prevent the metabolic conversion of codeine to its active metabolite morphine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Contraceptives (Estrogens): CloBAZam may decrease the serum concentration of Contraceptives (Estrogens).",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Contraceptives (Estrogens): May decrease the metabolism of Benzodiazepines (metabolized by oxidation).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Contraceptives (Progestins): CloBAZam may decrease the serum concentration of Contraceptives (Progestins).",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Contraceptives (Progestins): May increase the serum concentration of Benzodiazepines (metabolized by oxidation).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2C19 Inducers (Strong): May increase the metabolism of CYP2C19 Substrates. Management: Consider an alternative for one of the interacting drugs. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2C19 Inhibitors (Moderate): May decrease the metabolism of CYP2C19 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2C19 Inhibitors (Strong): May decrease the metabolism of CYP2C19 Substrates.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2D6 Substrates: CYP2D6 Inhibitors (Moderate) may decrease the metabolism of CYP2D6 Substrates.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Tamoxifen.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Deferiprone: UGT1A6 Inhibitors may increase the serum concentration of Deferiprone.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Droperidol: May enhance the CNS depressant effect of CNS Depressants. Management: Consider dose reductions of droperidol or of other CNS agents (e.g., opioids, barbiturates) with concomitant use.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fesoterodine: CYP2D6 Inhibitors may increase serum concentrations of the active metabolite(s) of Fesoterodine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fosaprepitant: May increase the serum concentration of Benzodiazepines (metabolized by oxidation). Specifically, the active metabolite aprepitant is likely responsible for this effect.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fosphenytoin: Benzodiazepines may increase the serum concentration of Fosphenytoin. Short-term exposure to benzodiazepines may not present as much risk as chronic therapy.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Grapefruit Juice: May decrease the metabolism of Benzodiazepines (metabolized by oxidation).",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     HydrOXYzine: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Isoniazid: May decrease the metabolism of Benzodiazepines (metabolized by oxidation).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Macrolide Antibiotics: May decrease the metabolism of Benzodiazepines (metabolized by oxidation).",
"     <b>",
"      Exceptions:",
"     </b>",
"     Azithromycin (Systemic); Fidaxomicin; Spiramycin.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Magnesium Sulfate: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methotrimeprazine: CNS Depressants may enhance the CNS depressant effect of Methotrimeprazine. Methotrimeprazine may enhance the CNS depressant effect of CNS Depressants.  Management: Reduce adult dose of CNS depressant agents by 50% with initiation of concomitant methotrimeprazine therapy. Further CNS depressant dosage adjustments should be initiated only after clinically effective methotrimeprazine dose is established.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metoprolol: CYP2D6 Inhibitors may increase the serum concentration of Metoprolol.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metyrosine: CNS Depressants may enhance the sedative effect of Metyrosine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mirtazapine: CNS Depressants may enhance the CNS depressant effect of Mirtazapine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Nebivolol: CYP2D6 Inhibitors (Moderate) may increase the serum concentration of Nebivolol.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     OLANZapine: May enhance the adverse/toxic effect of Benzodiazepines. Management: Avoid concomitant use of parenteral benzodiazepines and IM olanzapine due to risks of additive adverse events (e.g., cardiorespiratory depression). Olanzapine prescribing information provides no specific recommendations regarding oral administration.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Paraldehyde: CNS Depressants may enhance the CNS depressant effect of Paraldehyde.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Perampanel: May enhance the CNS depressant effect of CNS Depressants. Management: Patients taking perampanel with any other drug that has CNS depressant activities should avoid complex and high-risk activities, particularly those such as driving that require alertness and coordination, until they have experience using the combination.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Phenytoin: Benzodiazepines may increase the serum concentration of Phenytoin. Short-term exposure to benzodiazepines may not present as much risk as chronic therapy.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pramipexole: CNS Depressants may enhance the sedative effect of Pramipexole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Propafenone: May increase the serum concentration of CYP2D6 Inhibitors (Moderate).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Proton Pump Inhibitors: May increase the serum concentration of Benzodiazepines (metabolized by oxidation).",
"     <b>",
"      Exceptions:",
"     </b>",
"     Lansoprazole; Pantoprazole; RABEprazole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rifamycin Derivatives: May increase the metabolism of Benzodiazepines (metabolized by oxidation).",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ROPINIRole: CNS Depressants may enhance the sedative effect of ROPINIRole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rotigotine: CNS Depressants may enhance the sedative effect of Rotigotine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Saxagliptin: CYP3A4 Inducers may decrease the serum concentration of Saxagliptin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Selective Serotonin Reuptake Inhibitors: May decrease the metabolism of Benzodiazepines (metabolized by oxidation).",
"     <b>",
"      Exceptions:",
"     </b>",
"     Citalopram; Escitalopram; PARoxetine; Sertraline.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Selective Serotonin Reuptake Inhibitors: CNS Depressants may enhance the adverse/toxic effect of Selective Serotonin Reuptake Inhibitors. Specifically, the risk of psychomotor impairment may be enhanced.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Oxybate: Benzodiazepines may enhance the CNS depressant effect of Sodium Oxybate.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     St Johns Wort: May increase the metabolism of Benzodiazepines (metabolized by oxidation).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tamoxifen: CYP2D6 Inhibitors (Moderate) may decrease serum concentrations of the active metabolite(s) of Tamoxifen. Specifically, CYP2D6 inhibitors may decrease the metabolic formation of highly potent active metabolites.  Management: Consider alternatives with less of an inhibitory effect on CYP2D6 activity when possible.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Theophylline Derivatives: May diminish the therapeutic effect of Benzodiazepines.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Thioridazine: CYP2D6 Inhibitors may decrease the metabolism of Thioridazine.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     TraMADol: CYP2D6 Inhibitors (Moderate) may diminish the therapeutic effect of TraMADol. These CYP2D6 inhibitors may prevent the metabolic conversion of tramadol to its active metabolite that accounts for much of its opioid-like effects.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Yohimbine: May diminish the therapeutic effect of Antianxiety Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Zolpidem: CNS Depressants may enhance the CNS depressant effect of Zolpidem.  Management: Reduce the Intermezzo brand sublingual zolpidem dose to 1.75 mg for men who are also receiving other CNS depressants.  No such dose change is recommended for women.  Avoid use with other CNS depressants at bedtime; avoid use with alcohol.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F152588\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ethanol: Concomitant administration may increase bioavailability of clobazam by 50%. Ethanol may also increase CNS depression; monitor for increased effects with coadministration. Caution patients about effects.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Food: Serum concentrations may be increased by grapefruit juice.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Herb/Nutraceutical: St John's wort may decrease benzodiazepine levels. Avoid valerian, St John's wort, kava kava, gotu kola (may increase CNS depression).",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F152576\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Clobazam was shown to be teratogenic in some animal studies. Clobazam crosses the placenta. Teratogenic effects have been observed with some benzodiazepines; however, additional studies are needed. Epilepsy itself, the number of medications, genetic factors, or a combination of these probably influence the teratogenicity of anticonvulsant therapy. The incidence of premature birth and low birth weights may be increased following maternal use of benzodiazepines; hypoglycemia and respiratory problems in the neonate may occur following exposure late in pregnancy. Neonatal withdrawal symptoms may occur within days to weeks after birth and &ldquo;floppy infant syndrome&rdquo; (which also includes withdrawal symptoms) has been reported with some benzodiazepines. An increased risk of fetal malformations may be associated with first trimester exposure. The Canadian labeling contraindicates use  in the first trimester.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Patients exposed to clobazam during pregnancy are encouraged to enroll themselves into the AED Pregnancy Registry by calling 1-888-233-2334. Additional information is available at www.aedpregnancyregistry.org.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F152601\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Enters breast milk/not recommended",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F152578\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     May be taken with or without food.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F16323072\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Onfi Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     5 mg (100): $405.00",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     10 mg (100): $810.00",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     20 mg (100): $1620.00",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F10900438\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Respiratory and mental status/suicidality (eg, suicidal thoughts, depression, behavioral changes). The Canadian labeling recommends periodic CBC, liver function, renal function and thyroid function tests.",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F152579\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Aedon (IN);",
"     </li>",
"     <li>",
"      Anxirloc (ID);",
"     </li>",
"     <li>",
"      Castilium (PT);",
"     </li>",
"     <li>",
"      Clarmyl (ES);",
"     </li>",
"     <li>",
"      Clobam (PK);",
"     </li>",
"     <li>",
"      Clobamax (PE);",
"     </li>",
"     <li>",
"      Clobator (IN);",
"     </li>",
"     <li>",
"      Clobazam (PE);",
"     </li>",
"     <li>",
"      Clofritis (ID);",
"     </li>",
"     <li>",
"      Clopax (ES);",
"     </li>",
"     <li>",
"      Frisium (AT, AU, BE, BR, CR, CZ, DE, DK, DO, FI, GB, GR, GT, HK, HN, HU, IE, IL, IN, IT, LU, MY, NI, NL, NZ, PA, PK, PL, SG, SV, TH, TW, UY, VE);",
"     </li>",
"     <li>",
"      Grifoclobam (CN);",
"     </li>",
"     <li>",
"      Karidium (AR);",
"     </li>",
"     <li>",
"      Lucium (PY, UY);",
"     </li>",
"     <li>",
"      Noiafren (ES);",
"     </li>",
"     <li>",
"      Sederlona (ES);",
"     </li>",
"     <li>",
"      Sentil (KP);",
"     </li>",
"     <li>",
"      Urbadan (CO, EC, PE);",
"     </li>",
"     <li>",
"      Urbanil (BR);",
"     </li>",
"     <li>",
"      Urbanol (ZA);",
"     </li>",
"     <li>",
"      Urbanyl (CH, FR)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F152557\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Clobazam is a 1,5 benzodiazepine which binds to stereospecific benzodiazepine receptors on the postsynaptic GABA neuron at several sites within the central nervous system, including the limbic system, reticular formation. Enhancement of the inhibitory effect of GABA on neuronal excitability results by increased neuronal membrane permeability to chloride ions. This shift in chloride ions results in hyperpolarization (a less excitable state) and stabilization.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F152572\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Rapid; ~87%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: 80% to 90%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Hepatic via CYP3A4 and to a lesser extent via CYP2C19 and 2B6 (N-demethylation to active metabolite [N-desmethyl] with ~20% activity of clobazam). CYP2C19 primarily mediates subsequent hydroxylation of the N-desmethyl metabolite.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: 36-42 hours; N-desmethyl (active): 71-82 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak: 30 minutes to 4 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Urine (~94%), as metabolites",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Canadian Study Group for Childhood Epilepsy, &ldquo;Clobazam has Equivalent Efficacy to Carbamazepine and Phenytoin as Monotherapy for Childhood Epilepsy,&rdquo;",
"      <i>",
"       Epilepsia",
"      </i>",
"      , 1998, 39(9):952-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/49/40727/abstract-text/9738674/pubmed\" id=\"9738674\" target=\"_blank\">",
"        9738674",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Feely M and Gibson J, \"Intermittent Clobazam for Catamenial Epilepsy: Tolerance Avoided,\"",
"      <i>",
"       J Neurol Neurosurg Psychiatry",
"      </i>",
"      , 1984, 47(12):1279-82.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/49/40727/abstract-text/6392481/pubmed\" id=\"6392481\" target=\"_blank\">",
"        6392481",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Giraud C, Tran A, Rey E, et al, &ldquo;",
"      <i>",
"       In Vitro",
"      </i>",
"      Characterization of Clobazam Metabolism by Recombinant Cytochrome P450 Enzymes: Importance of CYP2C19,&rdquo;",
"      <i>",
"       Drug Metab Dispos",
"      </i>",
"      , 2004, 32(11):1279-86.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/49/40727/abstract-text/15483195/pubmed\" id=\"15483195\" target=\"_blank\">",
"        15483195",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Leahy JT, Chu-Shore CJ, and Fisher JL, \"Clobazam as an Adjunctive Therapy in Treating Seizures Associated With Lennox-Gastaut Syndrome,\"",
"      <i>",
"       Neuropsychiatr Dis Treat",
"      </i>",
"      , 2011, 7:673-81.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/49/40727/abstract-text/22128252/pubmed\" id=\"22128252\" target=\"_blank\">",
"        22128252",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Mokhlesi B, Leikin JB, Murray P, et al, &ldquo;Adult Toxicology in Critical Care: Part II: Specific Poisonings,&rdquo;",
"      <i>",
"       Chest",
"      </i>",
"      , 2003, 123(3):897-922.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/49/40727/abstract-text/12628894/pubmed\" id=\"12628894\" target=\"_blank\">",
"        12628894",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Montenegro MA, Cendes F, Noronha AL, et al, &ldquo;Efficacy of Clobazam as Add-On Therapy in Patients With Refractory Partial Epilepsy,&rdquo;",
"      <i>",
"       Epilepsia",
"      </i>",
"      , 2001, 42(4):539-42.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/49/40727/abstract-text/11440350/pubmed\" id=\"11440350\" target=\"_blank\">",
"        11440350",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Silva RC, Montenegro MA, Guerreiro CA, et al, &ldquo;Clobazam as Add-on Therapy in Children With Epileptic Encephalopathy,&rdquo;",
"      <i>",
"       Can J Neurol Sci",
"      </i>",
"      , 2006, 33(2):209-13.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/49/40727/abstract-text/16736732/pubmed\" id=\"16736732\" target=\"_blank\">",
"        16736732",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8719 Version 45.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-85.214.214.87-4FABCF92AE-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_49_40727=[""].join("\n");
var outline_f39_49_40727=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13688779\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F152592\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F152632\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F152596\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F152612\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F152597\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13689324\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F152598\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13688780\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10076209\">",
"      Dosage Forms: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15859539\">",
"      Product Availability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13689303\">",
"      Controlled Substance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13362239\">",
"      Medication Guide",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F152570\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F152569\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F152629\">",
"      Use - Unlabeled",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13689302\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F152630\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F152573\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F152558\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F152626\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F152562\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F152588\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F152576\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F152601\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F152578\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16323072\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10900438\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F152579\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F152557\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F152572\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8719\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8719|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?40/60/41924?source=related_link\">",
"      Clobazam: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?32/4/32839?source=related_link\">",
"      Clobazam: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f39_49_40728="Variant Creutzfeldt-Jakob disease";
var content_f39_49_40728=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Variant Creutzfeldt-Jakob disease",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/49/40728/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/49/40728/contributors\">",
"     Henry G Brown, MD, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/49/40728/contributors\">",
"     John M Lee, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/49/40728/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/49/40728/contributors\">",
"     Steven T DeKosky, MD, FAAN",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/49/40728/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/49/40728/contributors\">",
"     Janet L Wilterdink, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?39/49/40728/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 13, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prion diseases are neurodegenerative diseases that have long incubation periods and progress inexorably once clinical symptoms appear. Five human prion diseases are currently recognized: kuru, Creutzfeldt-Jakob disease (CJD), variant Creutzfeldt-Jakob disease (vCJD), Gerstmann-Str&auml;ussler-Scheinker syndrome (GSS), and fatal familial insomnia (FFI).",
"   </p>",
"   <p>",
"    These human prion diseases share certain common neuropathologic features including neuronal loss, proliferation of glial cells, absence of an inflammatory response, and the presence of small vacuoles within the neuropil, which produces a spongiform appearance.",
"   </p>",
"   <p>",
"    Variant CJD (vCJD) may be distinguished from cases of typical sporadic Creutzfeldt-Jakob disease (sCJD) by the following features:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      A considerably younger age at the onset of symptoms",
"     </li>",
"     <li>",
"      Less rapid progression of illness",
"     </li>",
"     <li>",
"      Differences in clinical presentation and course",
"     </li>",
"     <li>",
"      Differences in neuropathology",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The clinical manifestations and diagnosis of variant CJD will be reviewed here. Classic CJD (sporadic, iatrogenic and familial forms of CJD) is discussed separately. The prion diseases Kuru, GSS, and FFI are also discussed separately, as are the biology and genetics of prion diseases. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/62/30698?source=see_link\">",
"     \"Creutzfeldt-Jakob disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/28/31176?source=see_link\">",
"     \"Diseases of the central nervous system caused by prions\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/54/7017?source=see_link\">",
"     \"Biology and genetics of prions\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The initial reports in 1996 of cases of the new variant of CJD (vCJD) quickly focused intense interest on the human prion diseases, particularly because of the link with bovine spongiform encephalopathy (BSE) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40728/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. Unique epidemiologic features of this illness led to early recognition that this was indeed a \"new variant.\" (see",
"    <a class=\"local\" href=\"#H6\">",
"     'Clinical features'",
"    </a>",
"    below).",
"   </p>",
"   <p>",
"    The first report of a case of sporadic CJD in a 16-year-old from the United Kingdom appeared in 1995 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40728/abstract/3\">",
"     3",
"    </a>",
"    ] and was quickly followed in 1996 by 22 other cases of what was recognized as vCJD. All of these initial cases were from the United Kingdom except for one that was from France [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40728/abstract/1,4\">",
"     1,4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    As of August 2012, there have been a total of 224 cases of probable vCJD (dead and alive) reported worldwide, with 173 from the United Kingdom (UK), 27 from France, five in Spain, four in Ireland, three in the United States (US), three in Holland, two in Portugal, Canada and Italy, and one each in Japan, Taiwan, and Saudi Arabia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40728/abstract/5-7\">",
"     5-7",
"    </a>",
"    ]. Two of the Irish and US cases, as well as those in Canada, Japan, and Portugal are thought to have been infected while residing in the UK. The third US patient is thought to have been infected when living in Saudi Arabia. The other patients are believed to have been infected through meat products, animals, or animal products that were exported from the UK. Similarities between cases reported from different countries suggest that a common strain of infectious agent is involved and therefore a single source of infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40728/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The true prevalence of vCJD in the United Kingdom is unknown, but studies of lymphoreticular tissue, including tonsils and appendices, have estimated the prevalence to be 120 to 237 per million inhabitants [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40728/abstract/9,10\">",
"     9,10",
"    </a>",
"    ], based on the finding of three positive samples out of 12,674 samples screened [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40728/abstract/10\">",
"     10",
"    </a>",
"    ]. Methodological questions about sample selection and the broad confidence interval for the results (95% CI, 49-692 per million) suggest this estimate should be interpreted with caution.",
"   </p>",
"   <p>",
"    Evidence for a lower prevalence comes from two studies screening tonsillar tissue with no vCJD positive samples out of a total of over 5000 specimens screened [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40728/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. The stable to declining number of clinically recognized vCJD cases in the United Kingdom also supports a lower prevalence. Prospective collection and anonymous testing of tonsillar tissue for PrPSc in the United Kingdom was approved to begin in 2004 and may provide more accurate estimates of vCJD prevalence [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40728/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Relationship with BSE",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is increasing evidence supporting the possibility that vCJD represents bovine-to-human transmission of BSE [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40728/abstract/14\">",
"     14",
"    </a>",
"    ]. The appearance of vCJD followed an epidemic of BSE in the United Kingdom. The removal of organic solvents, which inactivate PrPSc, from the rendering process for bovine offal, and the subsequent use of the offal as a component of feed for cattle has been hypothesized to be a mechanism for amplifying the epidemic in animals.",
"   </p>",
"   <p>",
"    The source of BSE remains unclear. The first cases were recognized in 1986. Theories of its origination include the transmission of either sheep scrapie or another prion disease to cattle via contaminated feed; it has even been speculated that the original source was human CJD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40728/abstract/15\">",
"     15",
"    </a>",
"    ]. An intrinsic genetic event in cattle seems less likely.",
"   </p>",
"   <p>",
"    The demonstration that PrPSc adheres to certain soil minerals and remains infectious suggests the possibility that soil may represent a previously unidentified environmental reservoir for prions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40728/abstract/16\">",
"     16",
"    </a>",
"    ]. This may contribute to the transmission of prion diseases in sheep, deer, and elk through shedding from diseased animals and decomposition of infected carcasses. In support of this theory, BSE has been experimentally transmitted to sheep, which subsequently demonstrate infectivity in the absence of clinical symptoms (ie, are silent carriers of BSE) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40728/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Approximately 50,000 infected cattle are estimated to have entered the human food chain [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40728/abstract/14\">",
"     14",
"    </a>",
"    ]. A number of governmental regulations in the United Kingdom, particularly the prohibition on ruminant-derived proteins in feeds for all animals and poultry in November 1990 and the banning of consumption of animals over the age of 30 months in March 1996, the incidence of BSE, and the resulting risk of human exposure to BSE, have led to a dramatic decline in cases of BSE.",
"   </p>",
"   <p>",
"    Evidence in favor of the association of vCJD and BSE includes the type 4 pattern of PrPSc (Collinge nomenclature), which has not been seen in other prion diseases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40728/abstract/14\">",
"     14",
"    </a>",
"    ]. A case control study of vCJD in Great Britain associated a frequent consumption of beef and beef products and also chicken with increased risk for vCJD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40728/abstract/18\">",
"     18",
"    </a>",
"    ]. Surgical, occupational, and other animal exposures were similar between cases and controls. While recall bias may have contributed to these results, they support the hypothesis that dietary exposure is the main route of infection of vCJD. Despite the apparent link between vCJD and BSE, the number of cases of vCJD has remained small. Possible reasons for this observation include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Low levels of PrPSc in milk and meat, which are the main bovine products consumed",
"     </li>",
"     <li>",
"      Inefficiency of the oral route of infection",
"     </li>",
"     <li>",
"      Restriction of spread based upon a species barrier",
"     </li>",
"     <li>",
"      Low incidence of host genetic factors such as the frequency of homozygosity at codon 129",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     North American BSE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Renewed concern about vCJD was sparked with the finding in May 2003 of a cow with BSE from Alberta, Canada. The first BSE case in the United States, confirmed in December 2003, was found in a Washington state dairy cow that had been slaughtered with meat sent to market [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40728/abstract/19\">",
"     19",
"    </a>",
"    ]. The cow had been tested for BSE randomly because it was a \"downer,\" an animal unable to stand. Subsequent DNA analysis on the 6.5-year-old animal revealed that it had been born in Alberta, Canada. A number of beef importers from the United States closed their markets to further imports.",
"   </p>",
"   <p>",
"    The Canadian Food Inspection Agency (CFIA) confirmed in January 2005 that a second indigenous Alberta dairy cow born in 1996 (prior to the 1997 Canada ban on animal parts in feed) had tested positive for BSE. No part of the animal entered the human food or animal feed systems. As of January 2005, a total of three cases of BSE have been found in older cows originally from Alberta.",
"   </p>",
"   <p>",
"    The US Department of Agriculture (USDA) announced a series of measures designed to safeguard the food supply in December 2003, including an immediate ban on the slaughter of \"downer\" cattle for food consumption, holding for later release carcasses of animals tested for BSE until the tests are negative, and prohibition of use of advanced meat recovery specimens from skull, brain, trigeminal ganglia, eyes, vertebral column, spinal cord, or dorsal root ganglia from cattle &ge;30 months of age at slaughter and tonsils and small intestine from all cattle. The United States tested 426,164 animals for BSE from June 1, 2004 through August 1, 2005. One cow originally traced to Canada was reported as positive in November 2004. Another was reported as having a non-definitive test result in July 2005, which will be followed for further testing. Updated USDA information regarding BSE testing is available online (",
"    <a class=\"external\" href=\"file://www.aphis.usda.gov/lpa/issues/bse_testing/test_results.html\">",
"     www.aphis.usda.gov/lpa/issues/bse_testing/test_results.html",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    In December 2004, the USDA announced a rule recognizing Canada as a \"minimal risk region\" for BSE. This permits resumption of imports of live cattle less than 30 months of age and certain other beef products from Canada to the United States as of March 7, 2005. The subsequent finding in January 2005 of another Alberta cow with BSE was not expected to have any impact on the scheduled implementation of the USDA rule.",
"   </p>",
"   <p>",
"    The USDA approach is based on guidelines established by the World Organization for Animal Health (Office International des Epizooties or OIE). Under the OIE guidelines, a country may be considered a minimal-risk country for BSE, if it has less than two BSE cases per million cattle over 24 months of age during each of the previous four consecutive years. Canada has roughly 5.5 million cattle over 24 months of age. Thus, up to 11 detected cases of BSE in the Canada cattle population would be permitted in a four-consecutive-year period in the minimal-risk country category, as long as Canadian risk mitigation and other preventive measures were thought to be effective.",
"   </p>",
"   <p>",
"    Updated information on the number of BSE cases reported throughout the world in imported or indigenous cattle is available online from the OIE website (",
"    <a class=\"external\" href=\"file://www.oie.int/\">",
"     www.oie.int",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Transfusion-related vCJD",
"    </span>",
"    &nbsp;&mdash;&nbsp;Four, possibly five, cases of transfusion transmission of vCJD in the United Kingdom have been reported. One case involved the onset of vCJD in a patient 6.5 years after a transfusion of red cells; the donor had developed symptoms of vCJD 3.5 years after donation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40728/abstract/20\">",
"     20",
"    </a>",
"    ]. Although this association raised the possibility of transfusion-associated transmission of vCJD, dietary exposure to bovine spongiform encephalopathy (BSE) in the recipient could not be excluded.",
"   </p>",
"   <p>",
"    The second case involved a recipient who died five years after receiving a blood transfusion with no evidence of a neurologic disorder. The donor developed symptoms of vCJD 18 months after donation, and vCJD was confirmed in the donor at autopsy. The recipient was found to have protease-resistant prion protein in splenic but not brain tissue at autopsy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40728/abstract/21\">",
"     21",
"    </a>",
"    ]. Since the recipient was heterozygous at codon 129 of PRNP, the detection of protease-resistant prion protein in this individual suggests that susceptibility to vCJD infection is not confined to the methionine homozygous PRNP genotype. (See",
"    <a class=\"local\" href=\"#H10\">",
"     'Evaluation and diagnosis'",
"    </a>",
"    below.) The PRNP codon 129 genotype may limit the prion load or distribution in tissues as well as the clinical expression of disease, making the public health implications of this report less clear [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40728/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The third patient was diagnosed with vCJD premortem and had postmortem pathologic confirmation of disease 15 months after presentation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40728/abstract/23\">",
"     23",
"    </a>",
"    ]. He presented in 2005 with a six-month history of progressive neurologic deficits. He had ulcerative colitis and had received a transfusion in 1997 (7.5 years earlier) after a complicated surgical procedure. One of the blood donors had developed vCJD 20 months after donating the blood and had pathologic confirmation of the disease at postmortem 11 months later. Both donor and recipient were homozygous for methionine at PRNP codon 129. The same blood donor in the third case was implicated in the fourth patient with probably transfusion-related vCJD, who developed symptoms of vCJD 8.5 years after receiving a blood transfusion [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40728/abstract/7,24\">",
"     7,24",
"    </a>",
"    ]. Investigation of a fifth possible case of transfusion-related vCJD suggests that it may instead have occurred by transmission of BSE [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40728/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Studies in mice infected with vCJD have demonstrated that secondary infection can occur in MV and VV as well as in MM lines [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40728/abstract/26\">",
"     26",
"    </a>",
"    ]. In this study, MM and MV lines were the most susceptible to transmission. This, with a long preclinical phase predicted in these models, suggests that transfusion-related vCJD may represent a persistent health risk. Further cause for concern comes from case reports of Kuru after more than 50 years of incubation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40728/abstract/27\">",
"     27",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/54/7017?source=see_link\">",
"     \"Biology and genetics of prions\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    New restrictions were instituted in the United Kingdom in 2004 because of the demonstration of probable blood borne vCJD transmission [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40728/abstract/28\">",
"     28",
"    </a>",
"    ]. Recipients of blood, plasma, or tissue since 1980 were excluded as donors. In addition, recipients of vCJD-implicated plasma products and their physicians were being contacted and asked to inform other practitioners of their status in advance of any future medical, surgical, or dental treatment. Beginning in November, 1999, leukocyte depletion of all blood components was mandated in the United Kingdom in order to reduce the concentration of transmissible agents [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40728/abstract/29\">",
"     29",
"    </a>",
"    ]. All four documented cases of transfusion-related vCJD received transfusions of non-leukocyte depleted red blood cells between 1996 and 1999 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40728/abstract/7\">",
"     7",
"    </a>",
"    ]. Other risk-reduction measures, including a blood-based assay to detect vCJD, are in development [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40728/abstract/30-35\">",
"     30-35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The US Food and Drug Administration (FDA) adopted a policy that a prospective blood donor be indefinitely deferred if he or she had lived for more than six months in the United Kingdom during the peak years of BSE (1981 through 1996) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40728/abstract/36\">",
"     36",
"    </a>",
"    ]. This policy went into effect in April, 2000, to attempt to balance increased safety against decreased blood availability.",
"   </p>",
"   <p>",
"    The American Red Cross has adopted even more stringent deferral criteria. These include deferral of anyone receiving a blood transfusion in the United Kingdom, anyone residing or visiting the United Kingdom for three or more months since 1980, and anyone visiting or residing in another European country, Turkey, or Oman for six or more months since 1980. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/14/11498?source=see_link\">",
"     \"Blood donor medical history\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    While several countries have started to restrict persons who have received a blood transfusion from donating blood, such a policy would not have prevented the first two cases of tranfusion-related vCJD discussed above. Furthermore, a mathematical model based on epidemiologic data suggests that such a policy would prevent less than 1 percent of future vCJD cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40728/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There is no evidence of vertical transmission (mother to child) of vCJD, although the potentially long incubation period for this mechanism makes it difficult to exclude this possibility definitively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40728/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The mean age at onset of vCJD in the initial report was 29 years (range 16 to 48 years) compared with 65 years for sCJD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40728/abstract/39\">",
"     39",
"    </a>",
"    ]. However, patients presenting with vCJD at ages 11 and 74 years have subsequently been reported [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40728/abstract/40-42\">",
"     40-42",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients with vCJD frequently displayed prominent sensory disturbances and psychiatric symptoms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40728/abstract/40-42\">",
"     40-42",
"    </a>",
"    ]. Psychiatric symptoms are the presenting manifestations in 60 to 65 percent of patients and include depression, apathy, anxiety, irritability, social withdrawal, agitation, and insomnia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40728/abstract/42-44\">",
"     42-44",
"    </a>",
"    ]. A minority have psychosis (delusions, hallucinations).",
"   </p>",
"   <p>",
"    A smaller proportion of patients present with neurologic symptoms as the initial manifestations of disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40728/abstract/39,42-45\">",
"     39,42-45",
"    </a>",
"    ]. Sensory abnormalities may be seen early on and include dysesthesias and paresthesias of the face, hands, feet, legs, or even the hemibody, often without abnormalities on examination. As the disease progresses, other neurologic signs, gait ataxia and dysarthria appear, quickly followed by cognitive impairment, involuntary movements, immobility, unresponsiveness, and mutism. Paresis of upward gaze was noted in 50 percent of the initial patients, an uncommon sign in other forms of CJD.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     GENETICS",
"    </span>",
"    &nbsp;&mdash;&nbsp;PRNP gene mutations are not present in vCJD, but virtually all patients with clinically expressed vCJD have been homozygous for methionine at codon 129. Other candidate loci have been identified [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40728/abstract/46\">",
"     46",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/54/7017?source=see_link\">",
"     \"Biology and genetics of prions\"",
"    </a>",
"    .) It is estimated that 40 percent of the population in the United Kingdom has this genotype [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40728/abstract/28\">",
"     28",
"    </a>",
"    ]. A few possible exceptions have been reported [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40728/abstract/47\">",
"     47",
"    </a>",
"    ], including, as noted above, a patient without neurologic disease who was found to have protease-resistant prion protein in the spleen at autopsy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40728/abstract/21\">",
"     21",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H5\">",
"     'Transfusion-related vCJD'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     PrPSc type",
"    </span>",
"    &nbsp;&mdash;&nbsp;Type 2 PrPSc (Parchi and Gambetti nomenclature [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40728/abstract/48,49\">",
"     48,49",
"    </a>",
"    ], analogous to type 4 PrPSc in the Collinge nomenclature [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40728/abstract/50-52\">",
"     50-52",
"    </a>",
"    ]) is not characteristic of other human prion diseases, but this type has been found in patients with vCJD; this finding has helped to establish an association with BSE [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40728/abstract/14\">",
"     14",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H3\">",
"     'Relationship with BSE'",
"    </a>",
"    above.) The PrPSc associated with vCJD appears to be remarkably stereotyped, unlike the heterogeneity that exists for the PrPSc associated with sCJD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40728/abstract/53\">",
"     53",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/62/30698?source=see_link&amp;anchor=H15#H15\">",
"     \"Creutzfeldt-Jakob disease\", section on 'Molecular subtypes of sCJD'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Another feature that distinguishes vCJD from sCJD is its prominent trophism for lymphoid organs such as the tonsils [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40728/abstract/54-59\">",
"     54-59",
"    </a>",
"    ]. This property may facilitate the determination of vCJD prevalence and detection of subclinical prion infection by examination of tonsillar tissue [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40728/abstract/9,10,12,60\">",
"     9,10,12,60",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Epidemiology'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H14\">",
"     'Tonsillar tissue'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     NEUROPATHOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of neuropathologic features distinguish vCJD from sCJD. The most prominent is the presence of amyloid plaques, which stain intensely for PrPSc, distributed throughout the cerebrum and cerebellum and to a lesser degree the basal ganglia and thalamus [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40728/abstract/1\">",
"     1",
"    </a>",
"    ]. The plaques have an eosinophilic center and pale periphery with surrounding spongiform changes (\"florid\" and \"cluster\" plaques) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40728/abstract/61\">",
"     61",
"    </a>",
"    ]. Cases of kuru and GSS have similar, but not identical, plaques. As noted above, PrPSc extracted from the brains of vCJD cases also has the distinct type 4 pattern, determined by electrophoretic mobility and glycosylation pattern [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40728/abstract/50\">",
"     50",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     EVALUATION AND DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lumbar puncture, neuroimaging, electroencephalography, examination of tonsillar tissue, and brain biopsy all may be part of the evaluation of the patient with possible vCJD. Magnetic resonance imaging is the most useful noninvasive test in the positive diagnosis of vCJD.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Lumbar puncture",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cerebrospinal fluid (CSF) studies are rarely helpful in the diagnosis of vCJD, but may be performed to exclude infections and other possible causes of the patient&rsquo;s symptoms. In the original series of 14 patients, the cerebrospinal fluid (CSF) had no cells in any of the patients and a mildly elevated protein in four [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40728/abstract/39\">",
"     39",
"    </a>",
"    ]. Detection of the 14-3-3 protein in CSF is not a sensitive marker for vCJD. The protein has been detected in CSF of fewer than half of the patients tested. It was subsequently suggested that the combination of a CSF 14-3-3 protein assay and measurement of CSF tau protein may be useful in the identification of patients with vCJD, but additional studies are required to determine the sensitivity and specificity of combining these CSF markers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40728/abstract/62,63\">",
"     62,63",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Neuroimaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Magnetic resonance imaging (MRI) of the brain in vCJD may show signal hyperintensity in the pulvinar (pulvinar sign) or in both pulvinar and dorsomedial thalamus (hockey stick sign) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40728/abstract/64\">",
"     64",
"    </a>",
"    ]. In one series, 28 of 36 cases of vCJD and none of 57 controls demonstrated prominent bilateral pulvinar high signal, for a sensitivity and specificity of 78 and 100 percent, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40728/abstract/65\">",
"     65",
"    </a>",
"    ]. The pulvinar sign may disappear in follow-up MRIs [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40728/abstract/66,67\">",
"     66,67",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Fluid-attenuated inversion-recovery (FLAIR) images appear to be the most sensitive sequence for identifying this sign; diffusion-weighted imaging (DWI) may also show these abnormalities, but the potential sensitivity of this technique in vCJD is undetermined [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40728/abstract/66\">",
"     66",
"    </a>",
"    ]. However, DWI may be more sensitive than conventional MRI in detecting abnormalities in sCJD. The utility of DWI is discussed in the section on sCJD. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/62/30698?source=see_link&amp;anchor=H18#H18\">",
"     \"Creutzfeldt-Jakob disease\", section on 'MR imaging'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Head CT is usually normal. Single photon emission computed tomography (SPECT) has demonstrated decreased perfusion in four patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40728/abstract/68\">",
"     68",
"    </a>",
"    ], but the clinical utility of SPECT for this condition has not been demonstrated in large studies.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Electroencephalography",
"    </span>",
"    &nbsp;&mdash;&nbsp;The periodic sharp wave complexes (PSWCs) characteristic of sCJD are generally not seen in vCJD, except rarely in the later stages of disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40728/abstract/67,69,70\">",
"     67,69,70",
"    </a>",
"    ]. The electroencephalogram (EEG) was abnormal in 70 percent of the initial patients with vCJD, but usually only displayed a slow wave pattern [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40728/abstract/39\">",
"     39",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/62/30698?source=see_link&amp;anchor=H22#H22\">",
"     \"Creutzfeldt-Jakob disease\", section on 'Electroencephalogram'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Tonsillar tissue",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tissue demonstration of PrPSc requires limited protease digestion of tissue samples followed by Western blotting [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40728/abstract/60\">",
"     60",
"    </a>",
"    ]. Analysis of PrP extracted from tonsil biopsy tissue using this technique appears to provide a sensitive and specific method for the diagnosis of vCJD in the appropriate clinical context [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40728/abstract/54,55,71\">",
"     54,55,71",
"    </a>",
"    ]. The use of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?18/9/18583?source=see_link\">",
"     streptomycin",
"    </a>",
"    precipitation holds promise for rapidly and reliably diagnosing CJD with relatively small tissue samples [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40728/abstract/72\">",
"     72",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a study of 20 patients with suspected vCJD, tonsillar tissue was positive for PrPSc by Western blot or immunohistochemistry in all eight patients whose subsequent course either confirmed or was highly consistent with vCJD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40728/abstract/54\">",
"     54",
"    </a>",
"    ]. In addition, tonsillar tissue was negative for PrPSc in all patients subsequently confirmed to have non-vCJD diagnoses. Thus, this test appeared to correlate highly with the diagnosis of vCJD and not with other forms of prion disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3630344\">",
"    <span class=\"h2\">",
"     Diagnostic criteria",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diagnostic criteria for vCJD based upon clinical features and diagnostic test results have been developed and validated [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40728/abstract/42,70,73\">",
"     42,70,73",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Definite vCJD requires the presence of a progressive neuropsychiatric disorder and",
"      <span class=\"nowrap\">",
"       neuropathological/biochemical",
"      </span>",
"      confirmation of vCJD (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Neuropathology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Probable vCJD requires a progressive neuropsychiatric disorder, with a duration of illness &gt;6 months, with routine investigations that do not suggest an alternative diagnosis, no history of a potential iatrogenic exposure, no family history of transmissible spongiform encephalopathy AND four of five following clinical features: early psychiatric features, persistent painful sensory symptoms, ataxia, myoclonus or chorea or dystonia, dementia AND bilateral pulvinar signal on MRI or absent periodic sharp wave complexes.",
"     </li>",
"     <li>",
"      Probable vCJD can also be diagnosed in the presence of a progressive neuropsychiatric disorder and a positive tonsil biopsy.",
"     </li>",
"     <li>",
"      Possible vCJD requires a progressive neuropsychiatric disorder, with a duration of illness &gt;6 months, with routine investigations that do not suggest an alternative diagnosis, no history of a potential iatrogenic exposure, no family history of transmissible spongiform encephalopathy AND four of five following clinical features: early psychiatric features, persistent painful sensory symptoms, ataxia, myoclonus or chorea or dystonia, dementia AND absent periodic sharp wave complexes.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In one case series, of confirmed and suspected cases of vCJD, 83 percent of confirmed cases were classified as probable in life; no cases ultimately disproven to be vCJD met criteria for probable vCJD in life [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40728/abstract/73\">",
"     73",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3630422\">",
"    <span class=\"h2\">",
"     Differential diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The early symptoms of vCJD are nonspecific; depression and other psychiatric disease are commonly considered as the initial diagnosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40728/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Once neurologic symptoms appear, the differential diagnosis usually broadens to include sporadic CJD, Alzheimer disease, paraneoplastic disease or malignancy, viral encephalitis, frontotemporal dementia, demyelination, vasculitis subacute sclerosing panencephalitis, cerebrovascular disease, multisystem atrophy, Huntington disease, Wilson&rsquo;s disease, and autoimmune limbic encephalitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40728/abstract/42,73\">",
"     42,73",
"    </a>",
"    ]. MRI findings, laboratory studies, and lumbar puncture typically help exclude many of these diagnoses and provide evidence of vCJD.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     PROGNOSIS AND TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The mean duration of illness for variant CJD is longer than for sporadic CJD (14 versus 4 to 5 months) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40728/abstract/39,42\">",
"     39,42",
"    </a>",
"    ]. Both diseases are progressive and uniformly fatal.",
"   </p>",
"   <p>",
"    There is no known effective treatment for vCJD. Experience with the use of intraventricular pentosan polysulphate as a treatment for vCJD has been published in three case reports. Results have been mixed. In one 20-year-old man, treatment was associated with a relatively prolonged survival time (&gt;37 months), compared with the disease's natural history as well as some improvement in his neurologic status [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40728/abstract/74\">",
"     74",
"    </a>",
"    ]. In a 22-year-old man, survival time was also prolonged (51 months), but institution of treatment did not clearly correlate with a change in the rate of neurologic deterioration [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40728/abstract/75\">",
"     75",
"    </a>",
"    ]. This patient had had a prolonged course (19 months) even before treatment. In the third case, treatment had no discernable effect on the clinical course of the disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40728/abstract/76\">",
"     76",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?24/50/25378?source=see_link\">",
"       \"Patient information: Creutzfeldt-Jakob disease (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;New-variant Creutzfeldt-Jakob disease (vCJD) is a prion disease, first reported in 1996. As of August 2012, there have been a total of 224 cases of probable vCJD (dead and alive) reported worldwide.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The available evidence suggest that vCJD represents bovine-to-human transmission of bovine spongiform encephalopathy, with most patients acquiring the disorder through ingestion of infected meat products. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Relationship with BSE'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Cases of transfusion transmission of vCJD have been reported. Efforts to reduce the spread of vCJD via transfusions include leukocyte depletion of all blood components, now mandated in the United Kingdom and restricting at-risk individuals from donating blood. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Transfusion-related vCJD'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Similar to sporadic CJD, vCJD presents with a progressive course of cognitive decline with prominent neuropsychiatric features often accompanied by sensory symptoms. vCJD presents at a younger age than sporadic CJD and has a more protracted course. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Clinical features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A number of neuropathologic features distinguish vCJD from sCJD. The most prominent is the presence of florid or cluster amyloid plaques, which stain intensely for PrPSc, distributed throughout the cerebrum and cerebellum and to a lesser degree the basal ganglia and thalamus. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Neuropathology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Signal hyperintensity in the pulvinar (pulvinar sign) or in both the pulvinar and dorsomedial thalamus (hockey stick sign) on brain MRI is a useful finding with relatively high sensitivity and specificity for vCJD in the appropriate clinical setting. Analysis of PrP extracted from tonsil biopsy tissue also appears to provide a sensitive and specific method for the diagnosis of vCJD in the appropriate clinical context. Detection of the 14-3-3 protein in CSF is not a sensitive marker for vCJD. The periodic sharp wave complexes characteristic of sCJD are generally not seen in vCJD. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Evaluation and diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The mean duration of illness for variant CJD is longer than for sporadic CJD (14 versus 4 to 5 months). There is no known effective treatment for vCJD. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Prognosis and treatment'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40728/abstract/1\">",
"      Will RG, Ironside JW, Zeidler M, et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 1996; 347:921.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40728/abstract/2\">",
"      Collinge J, Rossor M. A new variant of prion disease. Lancet 1996; 347:916.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40728/abstract/3\">",
"      Britton TC, al-Sarraj S, Shaw C, et al. Sporadic Creutzfeldt-Jakob disease in a 16-year-old in the UK. Lancet 1995; 346:1155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40728/abstract/4\">",
"      Chazot G, Broussolle E, Lapras Cl, et al. New variant of Creutzfeldt-Jakob disease in a 26-year-old French man. Lancet 1996; 347:1181.",
"     </a>",
"    </li>",
"    <li>",
"     National Creutzfeldt-Jakob Disease Surveillance Unit. Edinburgh, Scotland file://www.cjd.ed.ac.uk/vcjdworld.htm (Accessed on August 13, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40728/abstract/6\">",
"      La Bella V, Collinge J, Pocchiari M, Piccoli F. Variant Creutzfeldt-Jakob disease in an Italian woman. Lancet 2002; 360:997.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40728/abstract/7\">",
"      Turner ML, Ludlam CA. An update on the assessment and management of the risk of transmission of variant Creutzfeldt-Jakob disease by blood and plasma products. Br J Haematol 2009; 144:14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40728/abstract/8\">",
"      Brandel JP, Heath CA, Head MW, et al. Variant Creutzfeldt-Jakob disease in France and the United Kingdom: Evidence for the same agent strain. Ann Neurol 2009; 65:249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40728/abstract/9\">",
"      Hilton DA, Ghani AC, Conyers L, et al. Accumulation of prion protein in tonsil and appendix: review of tissue samples. BMJ 2002; 325:633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40728/abstract/10\">",
"      Hilton DA, Ghani AC, Conyers L, et al. Prevalence of lymphoreticular prion protein accumulation in UK tissue samples. J Pathol 2004; 203:733.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40728/abstract/11\">",
"      Ironside JW, Hilton DA, Ghani A, et al. Retrospective study of prion-protein accumulation in tonsil and appendix tissues. Lancet 2000; 355:1693.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40728/abstract/12\">",
"      Frosh A, Smith LC, Jackson CJ, et al. Analysis of 2000 consecutive UK tonsillectomy specimens for disease-related prion protein. Lancet 2004; 364:1260.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40728/abstract/13\">",
"      Clewley JP, Kelly CM, Andrews N, et al. Prevalence of disease related prion protein in anonymous tonsil specimens in Britain: cross sectional opportunistic survey. BMJ 2009; 338:b1442.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40728/abstract/14\">",
"      Collinge J. Variant Creutzfeldt-Jakob disease. Lancet 1999; 354:317.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40728/abstract/15\">",
"      Colchester AC, Colchester NT. The origin of bovine spongiform encephalopathy: the human prion disease hypothesis. Lancet 2005; 366:856.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40728/abstract/16\">",
"      Johnson CJ, Phillips KE, Schramm PT, et al. Prions adhere to soil minerals and remain infectious. PLoS Pathog 2006; 2:e32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40728/abstract/17\">",
"      Bencsik A, Baron T. Bovine spongiform encephalopathy agent in a prion protein (PrP)ARR/ARR genotype sheep after peripheral challenge: complete immunohistochemical analysis of disease-associated PrP and transmission studies to ovine-transgenic mice. J Infect Dis 2007; 195:989.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40728/abstract/18\">",
"      Ward HJ, Everington D, Cousens SN, et al. Risk factors for variant Creutzfeldt-Jakob disease: a case-control study. Ann Neurol 2006; 59:111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40728/abstract/19\">",
"      Centers for Disease Control and Prevention (CDC). Bovine spongiform encephalopathy in a dairy cow--Washington state, 2003. MMWR Morb Mortal Wkly Rep 2004; 52:1280.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40728/abstract/20\">",
"      Llewelyn CA, Hewitt PE, Knight RS, et al. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 2004; 363:417.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40728/abstract/21\">",
"      Peden AH, Head MW, Ritchie DL, et al. Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 2004; 364:527.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40728/abstract/22\">",
"      Wilson K, Ricketts MN. Transfusion transmission of vCJD: a crisis avoided? Lancet 2004; 364:477.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40728/abstract/23\">",
"      Wroe SJ, Pal S, Siddique D, et al. Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report. Lancet 2006; 368:2061.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40728/abstract/24\">",
"      Editorial team. Fourth case of transfusion-associated vCJD infection in the United Kingdom. Euro Surveill 2007; 12:E070118.4.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40728/abstract/25\">",
"      Chohan G, Llewelyn C, Mackenzie J, et al. Variant Creutzfeldt-Jakob disease in a transfusion recipient: coincidence or cause? Transfusion 2010; 50:1003.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40728/abstract/26\">",
"      Bishop MT, Hart P, Aitchison L, et al. Predicting susceptibility and incubation time of human-to-human transmission of vCJD. Lancet Neurol 2006; 5:393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40728/abstract/27\">",
"      Collinge J, Whitfield J, McKintosh E, et al. Kuru in the 21st century--an acquired human prion disease with very long incubation periods. Lancet 2006; 367:2068.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40728/abstract/28\">",
"      Bird SM. Attributable testing for abnormal prion protein, database linkage, and blood-borne vCJD risks. Lancet 2004; 364:1362.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40728/abstract/29\">",
"      Williamson LM. Leucocyte depletion of the blood supply - how will patients benefit? Br J Haematol 2000; 110:256.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40728/abstract/30\">",
"      Ludlam CA, Turner ML. Managing the risk of transmission of variant Creutzfeldt Jakob disease by blood products. Br J Haematol 2006; 132:13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40728/abstract/31\">",
"      Gregori L, Gurgel PV, Lathrop JT, et al. Reduction in infectivity of endogenous transmissible spongiform encephalopathies present in blood by adsorption to selective affinity resins. Lancet 2006; 368:2226.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40728/abstract/32\">",
"      Wiltshire M, Thomas S, Scott J, et al. Prion reduction of red blood cells: impact on component quality. Transfusion 2010; 50:970.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40728/abstract/33\">",
"      Sowemimo-Coker SO, Demczyk CA, Andrade F, Baker CA. Evaluation of removal of prion infectivity from red blood cells with prion reduction filters using a new rapid and highly sensitive cell culture-based infectivity assay. Transfusion 2010; 50:980.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40728/abstract/34\">",
"      Guntz P, Walter C, Schosseler P, et al. Feasibility study of a screening assay that identifies the abnormal prion protein PrPTSE in plasma: initial results with 20,000 samples. Transfusion 2010; 50:989.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40728/abstract/35\">",
"      Edgeworth JA, Farmer M, Sicilia A, et al. Detection of prion infection in variant Creutzfeldt-Jakob disease: a blood-based assay. Lancet 2011; 377:487.",
"     </a>",
"    </li>",
"    <li>",
"     Center for Biologics Evaluation and Research, Food and Drug Administration: Guidance for Industry. Revised precautionary measures to reduce the possible risk of transmission of Creutzfeldt-Jacob disease and new variant Creutzfeldt-Jacob disease by blood and blood products. November 1999.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40728/abstract/37\">",
"      Dietz K, Raddatz G, Wallis J, et al. Blood transfusion and spread of variant Creutzfeldt-Jakob disease. Emerg Infect Dis 2007; 13:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40728/abstract/38\">",
"      Murray K, Peters J, Stellitano L, et al. Is there evidence of vertical transmission of variant Creutzfeldt-Jakob disease? J Neurol Neurosurg Psychiatry 2011; 82:729.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40728/abstract/39\">",
"      Zeidler M, Stewart GE, Barraclough CR, et al. New variant Creutzfeldt-Jakob disease: neurological features and diagnostic tests. Lancet 1997; 350:903.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40728/abstract/40\">",
"      Lorains JW, Henry C, Agbamu DA, et al. Variant Creutzfeldt-Jakob disease in an elderly patient. Lancet 2001; 357:1339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40728/abstract/41\">",
"      Barbot C, Castro L, Oliveira C, Carpenter S. Variant Creutzfeldt-Jakob disease: the first confirmed case from Portugal shows early onset, long duration and unusual pathology. J Neurol Neurosurg Psychiatry 2010; 81:112.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40728/abstract/42\">",
"      Heath CA, Cooper SA, Murray K, et al. Diagnosing variant Creutzfeldt-Jakob disease: a retrospective analysis of the first 150 cases in the UK. J Neurol Neurosurg Psychiatry 2011; 82:646.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40728/abstract/43\">",
"      Zeidler M, Johnstone EC, Bamber RW, et al. New variant Creutzfeldt-Jakob disease: psychiatric features. Lancet 1997; 350:908.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40728/abstract/44\">",
"      Spencer MD, Knight RS, Will RG. First hundred cases of variant Creutzfeldt-Jakob disease: retrospective case note review of early psychiatric and neurological features. BMJ 2002; 324:1479.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40728/abstract/45\">",
"      Cordery RJ, Alner K, Cipolotti L, et al. The neuropsychology of variant CJD: a comparative study with inherited and sporadic forms of prion disease. J Neurol Neurosurg Psychiatry 2005; 76:330.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40728/abstract/46\">",
"      Mead S, Poulter M, Uphill J, et al. Genetic risk factors for variant Creutzfeldt-Jakob disease: a genome-wide association study. Lancet Neurol 2009; 8:57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40728/abstract/47\">",
"      Kaski D, Mead S, Hyare H, et al. Variant CJD in an individual heterozygous for PRNP codon 129. Lancet 2009; 374:2128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40728/abstract/48\">",
"      Parchi P, Castellani R, Capellari S, et al. Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann Neurol 1996; 39:767.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40728/abstract/49\">",
"      Parchi P, Giese A, Capellari S, et al. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 1999; 46:224.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40728/abstract/50\">",
"      Collinge J, Sidle KC, Meads J, et al. Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD. Nature 1996; 383:685.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40728/abstract/51\">",
"      Wadsworth JD, Jackson GS, Hill AF, Collinge J. Molecular biology of prion propagation. Curr Opin Genet Dev 1999; 9:338.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40728/abstract/52\">",
"      Hill AF, Joiner S, Wadsworth JD, et al. Molecular classification of sporadic Creutzfeldt-Jakob disease. Brain 2003; 126:1333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40728/abstract/53\">",
"      Head MW, Bunn TJ, Bishop MT, et al. Prion protein heterogeneity in sporadic but not variant Creutzfeldt-Jakob disease: UK cases 1991-2002. Ann Neurol 2004; 55:851.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40728/abstract/54\">",
"      Hill AF, Butterworth RJ, Joiner S, et al. Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet 1999; 353:183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40728/abstract/55\">",
"      Wadsworth JD, Joiner S, Hill AF, et al. Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay. Lancet 2001; 358:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40728/abstract/56\">",
"      Glatzel M, Abela E, Maissen M, Aguzzi A. Extraneural pathologic prion protein in sporadic Creutzfeldt-Jakob disease. N Engl J Med 2003; 349:1812.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40728/abstract/57\">",
"      Glatzel M, Giger O, Seeger H, Aguzzi A. Variant Creutzfeldt-jakob disease: between lymphoid organs and brain. Trends Microbiol 2004; 12:51.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40728/abstract/58\">",
"      Adjou KT, Demaimay R, Deslys JP, et al. MS-8209, a water-soluble amphotericin B derivative, affects both scrapie agent replication and PrPres accumulation in Syrian hamster scrapie. J Gen Virol 1999; 80 ( Pt 4):1079.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40728/abstract/59\">",
"      Hilton DA, Sutak J, Smith ME, et al. Specificity of lymphoreticular accumulation of prion protein for variant Creutzfeldt-Jakob disease. J Clin Pathol 2004; 57:300.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40728/abstract/60\">",
"      Glatzel M. Testing for prions: a novel protocol for vCJD prevalence studies. Lancet 2004; 364:1196.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40728/abstract/61\">",
"      Ironside JW, Head MW. Neuropathology and molecular biology of variant Creutzfeldt-Jakob disease. Curr Top Microbiol Immunol 2004; 284:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40728/abstract/62\">",
"      Goodall CA, Head MW, Everington D, et al. Raised CSF phospho-tau concentrations in variant Creutzfeldt-Jakob disease: diagnostic and pathological implications. J Neurol Neurosurg Psychiatry 2006; 77:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40728/abstract/63\">",
"      Green AJ, Thompson EJ, Stewart GE, et al. Use of 14-3-3 and other brain-specific proteins in CSF in the diagnosis of variant Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 2001; 70:744.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40728/abstract/64\">",
"      Macfarlane RG, Wroe SJ, Collinge J, et al. Neuroimaging findings in human prion disease. J Neurol Neurosurg Psychiatry 2007; 78:664.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40728/abstract/65\">",
"      Zeidler M, Sellar RJ, Collie DA, et al. The pulvinar sign on magnetic resonance imaging in variant Creutzfeldt-Jakob disease. Lancet 2000; 355:1412.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40728/abstract/66\">",
"      Collie DA, Summers DM, Sellar RJ, et al. Diagnosing variant Creutzfeldt-Jakob disease with the pulvinar sign: MR imaging findings in 86 neuropathologically confirmed cases. AJNR Am J Neuroradiol 2003; 24:1560.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40728/abstract/67\">",
"      Yamada M, Variant CJD Working Group, Creutzfeldt-Jakob Disease Surveillance Committee, Japan. The first Japanese case of variant Creutzfeldt-Jakob disease showing periodic electroencephalogram. Lancet 2006; 367:874.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40728/abstract/68\">",
"      de Silva R, Patterson J, Hadley D, et al. Single photon emission computed tomography in the identification of new variant Creutzfeldt-Jakob disease: case reports. BMJ 1998; 316:593.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40728/abstract/69\">",
"      Binelli S, Agazzi P, Giaccone G, et al. Periodic electroencephalogram complexes in a patient with variant Creutzfeldt-Jakob disease. Ann Neurol 2006; 59:423.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40728/abstract/70\">",
"      Will RG, Zeidler M, Stewart GE, et al. Diagnosis of new variant Creutzfeldt-Jakob disease. Ann Neurol 2000; 47:575.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40728/abstract/71\">",
"      Hill AF, Zeidler M, Ironside J, Collinge J. Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy. Lancet 1997; 349:99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40728/abstract/72\">",
"      Quadrio I, Ugnon-Caf&eacute; S, Dupin M, et al. Rapid diagnosis of human prion disease using streptomycin with tonsil and brain tissues. Lab Invest 2009; 89:406.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40728/abstract/73\">",
"      Heath CA, Cooper SA, Murray K, et al. Validation of diagnostic criteria for variant Creutzfeldt-Jakob disease. Ann Neurol 2010; 67:761.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40728/abstract/74\">",
"      Todd NV, Morrow J, Doh-ura K, et al. Cerebroventricular infusion of pentosan polysulphate in human variant Creutzfeldt-Jakob disease. J Infect 2005; 50:394.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40728/abstract/75\">",
"      Parry A, Baker I, Stacey R, Wimalaratna S. Long term survival in a patient with variant Creutzfeldt-Jakob disease treated with intraventricular pentosan polysulphate. J Neurol Neurosurg Psychiatry 2007; 78:733.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40728/abstract/76\">",
"      Whittle IR, Knight RS, Will RG. Unsuccessful intraventricular pentosan polysulphate treatment of variant Creutzfeldt-Jakob disease. Acta Neurochir (Wien) 2006; 148:677.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5076 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-118.195.65.247-458F631DC3-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_49_40728=[""].join("\n");
var outline_f39_49_40728=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H16\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Relationship with BSE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      North American BSE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Transfusion-related vCJD",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      GENETICS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      PrPSc type",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      NEUROPATHOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      EVALUATION AND DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Lumbar puncture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Neuroimaging",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Electroencephalography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Tonsillar tissue",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3630344\">",
"      Diagnostic criteria",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3630422\">",
"      Differential diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      PROGNOSIS AND TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/54/7017?source=related_link\">",
"      Biology and genetics of prions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/14/11498?source=related_link\">",
"      Blood donor medical history",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/62/30698?source=related_link\">",
"      Creutzfeldt-Jakob disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/28/31176?source=related_link\">",
"      Diseases of the central nervous system caused by prions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?24/50/25378?source=related_link\">",
"      Patient information: Creutzfeldt-Jakob disease (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f39_49_40729="Clinical manifestations and diagnosis of Henoch-Schönlein purpura (IgA vasculitis)";
var content_f39_49_40729=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Clinical manifestations and diagnosis of Henoch-Sch&ouml;nlein purpura (IgA vasculitis)",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/49/40729/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/49/40729/contributors\">",
"     Fatma Dedeoglu, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/49/40729/contributors\">",
"     Susan Kim, MD, MMSc",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/49/40729/contributors\">",
"     Robert Sundel, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/49/40729/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/49/40729/contributors\">",
"     Marisa Klein-Gitelman, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/49/40729/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/49/40729/contributors\">",
"     Elizabeth TePas, MD, MS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?39/49/40729/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 8, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Henoch-Sch&ouml;nlein purpura (HSP), also called IgA vasculitis (IgAV) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40729/abstract/1\">",
"     1",
"    </a>",
"    ], is the most common form of systemic vasculitis in children. Ninety percent of cases occur in the pediatric age group. In contrast to many other forms of systemic vasculitis, HSP (IgAV) is self-limited in the great majority of cases. The disease is characterized by a tetrad of clinical manifestations:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Palpable purpura in patients with neither thrombocytopenia nor coagulopathy",
"     </li>",
"     <li>",
"      <span class=\"nowrap\">",
"       Arthritis/arthralgia",
"      </span>",
"     </li>",
"     <li>",
"      Abdominal pain",
"     </li>",
"     <li>",
"      Renal disease",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The clinical manifestations, pathogenesis, diagnosis, and differential diagnosis of HSP (IgAV) will be presented here. The management of HSP (IgAV) and a more complete discussion of the renal manifestations of HSP (IgAV) are found elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/62/28646?source=see_link\">",
"     \"Management of Henoch-Sch&ouml;nlein purpura (IgA vasculitis)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"./renal-manifestations-of-henoch-schonlein-purpura-iga-vasculitis?source=see_link\">",
"     \"Renal manifestations of Henoch-Sch&ouml;nlein purpura (IgA vasculitis)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;HSP (IgAV) is primarily a childhood disease that occurs between the ages of 3 and 15 years. In a population-based study from the United Kingdom, the annual incidence was about 20 per 100,000 in children &lt;17 years of age with a peak incidence of 70 per 100,000 in children between the ages of four and six years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40729/abstract/2\">",
"     2",
"    </a>",
"    ]. In reports from Taiwan and the Czech Republic, there was a lower incidence of 10 per 100,000 in children &lt;17 years of age with a peak incidence at five to seven years of age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40729/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. Although there are no comparable epidemiologic data, HSP (IgAV) is less common in adults [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40729/abstract/5\">",
"     5",
"    </a>",
"    ]. The rate of HSP (IgAV) is significantly higher (approximately 5 percent) in patients with familial Mediterranean fever [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40729/abstract/6,7\">",
"     6,7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There is a male predominance with reported male-to-female ratios of 1.2:1 to 1.8:1 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40729/abstract/2,3,8,9\">",
"     2,3,8,9",
"    </a>",
"    ]. HSP (IgAV) is seen less frequently in black compared to white or Asian children [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40729/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    HSP (IgAV) occurs primarily in the fall, winter, and spring, but rarely in the summer months [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40729/abstract/8-10\">",
"     8-10",
"    </a>",
"    ], possibly explained by the association of HSP (IgAV) with infections. About half of the cases of HSP (IgAV) are preceded by an upper respiratory infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40729/abstract/11\">",
"     11",
"    </a>",
"    ], especially those caused by streptococcus [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40729/abstract/12,13\">",
"     12,13",
"    </a>",
"    ]. Other infectious agents, vaccinations, and insect bites also have been implicated as possible triggers for HSP (IgAV) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40729/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;HSP (IgAV) is an immune-mediated vasculitis associated with immunoglobulin A (IgA) deposition. Although a variety of infectious and chemical triggers are recognized, the underlying cause of HSP (IgAV) remains unknown. Immunologic, genetic, and environmental factors all seem to play a role.",
"   </p>",
"   <p>",
"    The characteristic finding of HSP (IgAV) is leukocytoclastic vasculitis accompanied by IgA immune complexes within affected organs (",
"    <a class=\"graphic graphic_picture graphicRef52548 graphicRef66296 \" href=\"mobipreview.htm?7/58/8106\">",
"     picture 1A-B",
"    </a>",
"    ). Skin biopsies of purpuric lesions demonstrate the involvement of small vessels (primarily postcapillary venules) within the papillary dermis. The predominant cell types within the inflammatory infiltrate are neutrophils and monocytes.",
"   </p>",
"   <p>",
"    Immunofluorescence studies show IgA, C3, and fibrin deposition within the walls of involved vessels. IgA, C3, fibrin, IgG, and less commonly IgM also are deposited within the endothelial and mesangial cells of the kidney (",
"    <a class=\"graphic graphic_picture graphicRef69895 \" href=\"mobipreview.htm?23/2/23599\">",
"     picture 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Attention has focused on the potential role of increased serum levels of IgA and IgA immune complexes in the pathogenesis of HSP (IgAV). In addition, several studies report alterations in the glycosylation of IgA, elevated levels of IgA anticardiolipin antibodies, and increased levels of transforming growth factor-beta in patients with HSP (IgAV) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40729/abstract/9,14-18\">",
"     9,14-18",
"    </a>",
"    ]. The fact that only one of the two IgA subtypes (IgA1, but not IgA2) is found in the inflammatory infiltrates of this disease remains unexplained [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40729/abstract/19,20\">",
"     19,20",
"    </a>",
"    ]. Similarly, the precise role of IgA and the specific involvement of IgA1 in the pathogenesis of HSP (IgAV) remain unclear. Some research suggests that IgA anticardiolipin antibodies may play a role [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40729/abstract/14,21,22\">",
"     14,21,22",
"    </a>",
"    ]. Results from one study suggest that &beta;2-glycoprotein I (&beta;2GPI) is an antigenic target for IgA [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40729/abstract/23\">",
"     23",
"    </a>",
"    ]. Despite the increased presence of these antibodies, there are few reports of thrombosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS IN CHILDREN",
"    </span>",
"    &nbsp;&mdash;&nbsp;The classic tetrad of HSP (IgAV) includes:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Palpable purpura without thrombocytopenia and coagulopathy",
"     </li>",
"     <li>",
"      <span class=\"nowrap\">",
"       Arthritis/arthralgia",
"      </span>",
"     </li>",
"     <li>",
"      Abdominal pain",
"     </li>",
"     <li>",
"      Renal disease",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These clinical manifestations may develop over the course of days to weeks and may vary in their order of presentation. Purpura and joint pain are usually the presenting symptoms, but this is not always the case. In the absence of the classic purpuric rash, the diagnosis of HSP (IgAV) may not be obvious. Patients who present with significant joint or abdominal symptoms without the skin manifestations may be thought to have an infectious or surgical process.",
"   </p>",
"   <p>",
"    The mean age of onset of HSP (IgAV) is between six and seven years of age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40729/abstract/2,3,8,9\">",
"     2,3,8,9",
"    </a>",
"    ]. Based upon retrospective reviews from Taiwan, Italy, and the United States, the major clinical manifestations develop with the following frequencies (",
"    <a class=\"graphic graphic_table graphicRef60175 \" href=\"mobipreview.htm?24/8/24716\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40729/abstract/3,8,19\">",
"     3,8,19",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Purpura &mdash; All patients developed palpable purpura. This may be an overestimation as it is most likely that patients would not be considered for inclusion in these case series without characteristic skin findings.",
"     </li>",
"     <li>",
"      <span class=\"nowrap\">",
"       Arthralgia/arthritis",
"      </span>",
"      &mdash; In the American and Italian series, joint symptoms were the second most common manifestation, occurring in three-quarters of the patients. In the Taiwanese study, joint complaints were present in 43 percent of patients.",
"     </li>",
"     <li>",
"      Abdominal pain &mdash; Colicky pain occurred in about half of patients and gastrointestinal bleeding in approximately 20 to 30 percent of patients.",
"     </li>",
"     <li>",
"      Renal disease &mdash; The frequency of renal involvement ranged from 21 to 54 percent.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In the retrospective Italian review of 150 children with HSP (IgAV), the presenting symptom was purpura in 74 percent, arthritis in 15 percent, and abdominal pain in 12 percent of patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40729/abstract/8\">",
"     8",
"    </a>",
"    ]. Similar results were seen in a Spanish retrospective review of 78 patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40729/abstract/9\">",
"     9",
"    </a>",
"    ]; purpura, arthritis, and abdominal pain were the initial findings in 70, 12, and 17 percent of patients, respectively. A Finnish prospective study of 223 HSP (IgAV) patients reported rash as the presenting symptom in 73 percent, preceding other symptoms by a mean of four days [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40729/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Skin manifestations",
"    </span>",
"    &nbsp;&mdash;&nbsp;The classic rash of HSP (IgAV) is not the initial presenting sign in about one-quarter of affected children. It may be difficult to make the diagnosis of HSP (IgAV) prior to the appearance of a rash in patients who present with other clinical manifestations, such as abdominal pain or arthritis.",
"   </p>",
"   <p>",
"    The rash often begins with erythematous, macular, or urticarial wheals. The wheals then coalesce and evolve into the typical ecchymoses, petechiae, and palpable purpura (",
"    <a class=\"graphic graphic_picture graphicRef62546 \" href=\"mobipreview.htm?29/6/29794\">",
"     picture 3",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef63367 \" href=\"mobipreview.htm?32/32/33282\">",
"     picture 4",
"    </a>",
"    ). The rash typically appears in crops, symmetrically distributed, and located primarily in",
"    <span class=\"nowrap\">",
"     gravity/pressure-dependent",
"    </span>",
"    areas such as the lower extremities. The buttocks are often involved in toddlers, and the face, trunk, and upper extremities in nonambulatory children.",
"   </p>",
"   <p>",
"    Localized subcutaneous edema is a common feature that may be found in dependent and periorbital areas, especially in younger children (&lt;3 years of age). Even adult patients, however, may also have this manifestation of HSP (IgAV), particularly involving the dorsal aspect of the",
"    <span class=\"nowrap\">",
"     hands.",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Arthritis/arthralgia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Arthritis/arthralgia,",
"    which occur in up to 84 percent of patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40729/abstract/8\">",
"     8",
"    </a>",
"    ] are uncommon as the sole symptom at presentation. As previously noted,",
"    <span class=\"nowrap\">",
"     arthritis/arthralgia",
"    </span>",
"    are the presenting symptom in about 15 percent of patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40729/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The arthritis is usually transient or migratory, typically oligoarticular (one to four joints), and nondeforming. It usually affects the lower extremity large joints (hips, knees, and ankles), or less commonly the upper extremities (elbows, wrists, and hands) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40729/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]. There is often prominent periarticular swelling and tenderness, but usually without joint effusion, erythema, or warmth. Patients may have considerable pain and limitation of motion. Younger children with lower extremity involvement may refuse to ambulate. The arthritis does not cause any chronic damage or sequelae. It may precede the appearance of purpura, though usually by no more than one or two days.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Gastrointestinal symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gastrointestinal symptoms occur in about half of children with HSP (IgAV) and range from mild (nausea, vomiting, abdominal pain, and transient paralytic ileus) to more significant findings (gastrointestinal hemorrhage, bowel ischemia and necrosis, intussusception, and bowel perforation). Guaiac-positive stool is found in up to 56 percent of patients, but massive gastrointestinal hemorrhage is rare [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40729/abstract/25\">",
"     25",
"    </a>",
"    ]. The frequent presence of fecal occult blood, hypoalbuminemia without proteinuria, and positive alpha1-antitrypsin tests even in patients without gastrointestinal symptoms suggests that gastrointestinal involvement and mucosal injury is more common than the clinical history indicates [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40729/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Gastrointestinal symptoms typically develop within eight days of the appearance of the rash, although much longer intervals (weeks to months) have been described [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40729/abstract/26\">",
"     26",
"    </a>",
"    ]. Gastrointestinal complaints precede the rash in about 15 to 35 percent of cases, making the diagnosis of HSP (IgAV) less apparent in these patients. Gastrointestinal symptoms without the appearance of cutaneous purpura at any time also have been described in case reports [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40729/abstract/27-29\">",
"     27-29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Gastrointestinal pain associated with HSP (IgAV) is caused by submucosal hemorrhage and edema. Purpuric lesions may be seen on endoscopy, commonly in the descending duodenum, stomach, and colon. The terminal ileum also may be involved. Submucosal edema, ulceration, and spasm of the ileum and jejunum may be seen in small bowel series. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/24/24968?source=see_link\">",
"     \"Gastrointestinal manifestations of vasculitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Intussusception is the most common gastrointestinal complication of HSP (IgAV). Rarer gastrointestinal manifestations include acute pancreatitis, gall bladder involvement, bowel perforation, and, in children, a protein-losing enteropathy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40729/abstract/25,30-35\">",
"     25,30-35",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Intussusception",
"    </span>",
"    &nbsp;&mdash;&nbsp;Edema and hemorrhage can act as a pathological lead-point, contributing to the development of intussusception. Intussusception is limited to the small bowel in about 60 percent of cases, in contrast to idiopathic intussusception, which is typically ileocolic [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40729/abstract/36\">",
"     36",
"    </a>",
"    ]. Intussusception in HSP (IgAV) has a reported overall incidence of about 3.5 percent, although some retrospective series reported an incidence of only 0.4 to 0.6 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40729/abstract/8,25\">",
"     8,25",
"    </a>",
"    ]. This discrepancy may be due to differences in the population studied. Children demonstrating severe gastrointestinal pain",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    requiring hospitalization are presumably at greater risk.",
"   </p>",
"   <p>",
"    In a retrospective review of 149 hospitalized children with HSP (IgAV) from two centers in Chicago, 63 patients (42 percent) presented with severe abdominal pain [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40729/abstract/37\">",
"     37",
"    </a>",
"    ]. Four patients were diagnosed with intussusception, two of which were ileoileal intussusceptions. All four patients required surgical correction.",
"   </p>",
"   <p>",
"    In patients with HSP (IgAV), ultrasonography should be the initial screening test in cases of suspected intussusception. Although contrast enemas are the standard procedure in other clinical settings to diagnosis intussusception, they cannot detect ileoileal intussusception typically seen in HSP (IgAV). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/20/35145?source=see_link\">",
"     \"Intussusception in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Renal disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;The renal manifestations of HSP (IgAV), including prognosis and treatment, are discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"./renal-manifestations-of-henoch-schonlein-purpura-iga-vasculitis?source=see_link\">",
"     \"Renal manifestations of Henoch-Sch&ouml;nlein purpura (IgA vasculitis)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Summarized briefly, renal involvement has been reported in 20 to 54 percent of children with HSP (IgAV). It is apparently more prevalent in adults. The most common presentation is hematuria with or without red cell casts and no or mild proteinuria. Nephrotic range proteinuria, an elevated serum creatinine,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    hypertension, which are present in a minority of patients, are associated with an increased risk of progressive disease, which is more likely to occur in adults. The findings on renal biopsy are identical to those in IgA nephropathy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Other organ involvement",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other organ systems also may be involved:",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H37580706\">",
"    <span class=\"h3\">",
"     Scrotum",
"    </span>",
"    &nbsp;&mdash;&nbsp;Reports of scrotal involvement in boys with HSP (IgAV) range from 2 to 38 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40729/abstract/38-40\">",
"     38-40",
"    </a>",
"    ]. Rarely, scrotal pain may be the presenting symptom. Clinical findings include pain, tenderness, and swelling of the involved testicle",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    scrotum.",
"   </p>",
"   <p>",
"    The presentation may mimic testicular torsion. Evaluation including ultrasonography and technetium Tc99m radionuclide scanning can differentiate the two entities. In testicular torsion, these studies demonstrate decreased blood flow to the testicle, in contrast to the normal or increased flow seen in boys with HSP (IgAV).",
"   </p>",
"   <p>",
"    The clinical presentation of scrotal involvement in HSP (IgAV) was reviewed in a retrospective study of 120 Korean boys diagnosed with HSP (IgAV) between 1992 and 2004 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40729/abstract/41\">",
"     41",
"    </a>",
"    ]. Twenty-six patients (22 percent) had scrotal involvement, which presented as scrotal swelling (23 patients), scrotal pain or tenderness (18 patients), and bilateral involvement (seven patients). Scrotal pain was the initial finding of HSP (IgAV) in two of the patients. Imaging (ultrasonography",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    radionuclide scan) was performed in 15 patients and demonstrated epididymitis in 13 and orchitis in two patients. One patient underwent surgical exploration but there was no evidence of testicular torsion.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H37580713\">",
"    <span class=\"h3\">",
"     Central and peripheral nervous system",
"    </span>",
"    &nbsp;&mdash;&nbsp;Single reports and case series document neurologic manifestations including headaches, seizures, focal neurologic deficits, ataxia, intracerebral hemorrhage, and central and peripheral neuropathy in children with HSP (IgAV) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40729/abstract/42-44\">",
"     42-44",
"    </a>",
"    ]. Most of the central nervous system findings are transient except for occasional permanent sequelae associated with hemorrhagic stroke.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H37580720\">",
"    <span class=\"h3\">",
"     Respiratory tract",
"    </span>",
"    &nbsp;&mdash;&nbsp;In a cohort of French patients hospitalized for HSP (IgAV), impaired lung diffusion capacity and mild interstitial changes on chest radiographs were found in the majority of patients (97 and 69 percent, respectively), despite the absence of significant respiratory symptoms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40729/abstract/45\">",
"     45",
"    </a>",
"    ]. A retrospective review of HSP (IgAV) patients at the Mayo Clinic, on the other hand, identified only 3 of 124 patients with pulmonary involvement [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40729/abstract/46\">",
"     46",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Pulmonary hemorrhage is rare in patients with HSP (IgAV) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40729/abstract/47-49\">",
"     47-49",
"    </a>",
"    ]. It has primarily been reported in adults and adolescents [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40729/abstract/47\">",
"     47",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H37580808\">",
"    <span class=\"h3\">",
"     Eyes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Keratitis and uveitis are rare sequelae of HSP (IgAV) and usually suggest other diseases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40729/abstract/50\">",
"     50",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H37580530\">",
"    <span class=\"h2\">",
"     Recurrent disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Recurrence of HSP (IgAV) is reported in about one-third of affected children [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40729/abstract/8,19,51\">",
"     8,19,51",
"    </a>",
"    ] and generally occurs within four months of the initial episode. Recurrences tend to be milder and briefer than the initial episode, and they occur more commonly in patients with nephritis, in those with evidence of acute inflammation (eg, elevated erythrocyte sedimentation rate [ESR]), or in patients who received treatment with corticosteroids [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40729/abstract/8\">",
"     8",
"    </a>",
"    ]. These findings suggest that patients who have a more severe course of HSP (IgAV) are at increased risk of recurrence.",
"   </p>",
"   <p>",
"    One retrospective review from Israel reported a longer mean interval time of 13.5 months between the first and second episode of HSP (IgAV) than was reported previously [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40729/abstract/52\">",
"     52",
"    </a>",
"    ]. In addition, there was no difference in clinical and laboratory findings between patients with recurrent disease and those without recurrence. The reasons for these differences between study results are unclear.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS IN ADULTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Adult patients with HSP (IgAV) present with clinical manifestations similar to those that occur in children. There are two main differences between adults and children with HSP (IgAV):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Intussusception is rare in adults. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Intussusception'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Adults are at increased risk for developing significant renal involvement including end-stage renal disease [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/49/40729/abstract/5,53\">",
"       5,53",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Renal disease'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    This was best illustrated in a retrospective review of 250 French adults with HSP (IgAV) (median age 50 years). At presentation, clinical findings included palpable purpura (96 percent), arthritis (61 percent), and gastrointestinal symptoms (48 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40729/abstract/53\">",
"     53",
"    </a>",
"    ]. Almost one-third of patients had renal insufficiency (creatinine clearance &lt;50",
"    <span class=\"nowrap\">",
"     ml/min",
"    </span>",
"    per m2) within four months of presentation. At a median follow-up of 14.8 years, persistent renal impairment was seen in 80 patients (32 percent) of the original cohort, including end-stage renal failure in 27 patients and severe renal impairment (creatinine clearance &lt;30",
"    <span class=\"nowrap\">",
"     mL/min)",
"    </span>",
"    in another 32 patients. Potential explanations for the high prevalence of substantial renal impairment in this study include the possibility of selection bias (all patients in the study had renal disease severe enough to require renal biopsy), the long period of follow-up compared with other studies, and the possible role of comorbidities (eg, hypertension) in contributing to the progression of renal disease.",
"   </p>",
"   <p>",
"    Another retrospective series reviewed 68 adults with HSP (IgAV) who had a skin biopsy with leukocytoclastic vasculitis on histopathologic evaluation and IgA on direct immunofluorescence. In this patient group they found a higher rate of renal involvement in patients older than 40 years whose skin biopsies showed an absence of eosinophils, and a higher rate of gastrointestinal involvement in patients whose biopsies showed an absence of histiocytes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40729/abstract/54\">",
"     54",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A more complete discussion of the renal manifestations and the management of renal disease in patients with HSP (IgAV) is found separately. (See",
"    <a class=\"medical medical_review\" href=\"./renal-manifestations-of-henoch-schonlein-purpura-iga-vasculitis?source=see_link\">",
"     \"Renal manifestations of Henoch-Sch&ouml;nlein purpura (IgA vasculitis)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of HSP (IgAV) is usually based upon clinical manifestations of the disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40729/abstract/55\">",
"     55",
"    </a>",
"    ]. The diagnosis is straightforward when patients present with the classic signs and symptoms, especially palpable purpura of the lower extremities and buttocks. In patients with incomplete or unusual presentations, a biopsy of an affected organ (eg, skin or kidney) that demonstrates leukocytoclastic vasculitis with a predominance of IgA deposition confirms the diagnosis of HSP (IgAV).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Biopsy",
"    </span>",
"    &nbsp;&mdash;&nbsp;In pediatric patients, biopsy is reserved for patients with an unusual presentation of HSP (IgAV) (ie, no rash, or an atypical rash) or those with significant renal disease.",
"   </p>",
"   <p>",
"    In adult patients, because of the lower incidence of HSP (IgAV) beyond the pediatric age group, confirmation of the diagnosis by biopsy is more important.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Skin",
"    </span>",
"    &nbsp;&mdash;&nbsp;Biopsies of the skin, which sample the small blood vessels of the superficial dermis, are usually adequate to make the diagnosis of HSP (IgAV). Light microscopy studies (hematoxylin and eosin stains) demonstrate the classical leukocytoclastic vasculitis in postcapillary venules with IgA deposition that is pathognomonic of HSP (IgAV) (",
"    <a class=\"graphic graphic_picture graphicRef52548 graphicRef66296 \" href=\"mobipreview.htm?7/58/8106\">",
"     picture 1A-B",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40729/abstract/56\">",
"     56",
"    </a>",
"    ]. The biopsy should contain skin lesions that are less than 24 hours old because in more chronic lesions, vessel damage leads to nonspecific leakage of all isotypes of immunoglobulin. Immunofluorescence studies, essential to confirming the diagnosis of HSP (IgAV), generally require biopsy of a second skin site.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Kidney",
"    </span>",
"    &nbsp;&mdash;&nbsp;Renal biopsy is reserved for patients in whom the diagnosis is uncertain or if there is clinical evidence of severe renal involvement. HSP (IgAV) is characterized by IgA deposition in the mesangium on immunofluorescence microscopy that is identical to that in IgA nephropathy (",
"    <a class=\"graphic graphic_picture graphicRef69895 \" href=\"mobipreview.htm?23/2/23599\">",
"     picture 2",
"    </a>",
"    ). Light microscopy changes range from isolated mesangial proliferation to severe crescentic glomerulonephritis. (See",
"    <a class=\"medical medical_review\" href=\"./renal-manifestations-of-henoch-schonlein-purpura-iga-vasculitis?source=see_link\">",
"     \"Renal manifestations of Henoch-Sch&ouml;nlein purpura (IgA vasculitis)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Laboratory tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;No laboratory test is diagnostic for HSP (IgAV). Serum IgA levels have been reported to be elevated in 50 to 70 percent of patients with HSP (IgAV) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40729/abstract/9,15,57\">",
"     9,15,57",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Findings on routine blood tests (eg, complete blood cell count, serum chemistries, and urinalysis) are nonspecific. Results generally reflect the triggering condition: HSP (IgAV) following bacterial infections is more likely to be characterized by leukocytosis (white cell count &gt;20,000",
"    <span class=\"nowrap\">",
"     cells/mm3)",
"    </span>",
"    and an elevated erythrocyte sedimentation rate (ESR). HSP (IgAV) after viral illnesses, on the other hand, often fails to demonstrate evidence of systemic inflammation. Patients may have a normochromic anemia because of occult or overt gastrointestinal bleeding.",
"   </p>",
"   <p>",
"    Confirmation of a normal platelet count and coagulation studies (prothrombin time) are necessary when clinical features do not allow conclusive distinction of HSP (IgAV) from other diseases that present with purpura on account of thrombocytopenia or coagulopathy.",
"   </p>",
"   <p>",
"    Urinalysis should be performed in all patients with HSP (IgAV). In general, the findings reflect the degree of renal involvement and may include the presence of red or white cells, cellular casts, and proteinuria. Serum creatinine should be obtained in all adult patients with HSP (IgAV) because of the increased risk of significant renal disease. In children, renal disease is less prevalent, so serum creatinine need not be obtained unless there are abnormalities on the urinalysis. Renal involvement often becomes detectable after other manifestations of HSP (IgAV), so urinary screening should be continued beyond the acute presentation. (See",
"    <a class=\"medical medical_review\" href=\"./renal-manifestations-of-henoch-schonlein-purpura-iga-vasculitis?source=see_link\">",
"     \"Renal manifestations of Henoch-Sch&ouml;nlein purpura (IgA vasculitis)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Imaging studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Imaging studies generally are performed in patients with significant abdominal symptoms. Plain abdominal radiography may demonstrate dilated loops of bowel consistent with decreased intestinal motility. Abdominal ultrasonography can detect increased bowel wall thickness, hematomas, peritoneal fluid, and intussusception [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40729/abstract/9,36,37\">",
"     9,36,37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    If intussusception is considered, ultrasonography rather than contrast enemas should be the initial screening test. Ileoileal intussusception is seen in more than half of the cases of intussusception in patients with HSP (IgAV). Contrast enemas, usually indicated in children with signs of an intussusception, neither detect nor help reduce ileoileal intussusception.",
"   </p>",
"   <p>",
"    In boys who present with scrotal symptoms, Doppler flow studies",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    radionuclide scans can distinguish scrotal pain caused by HSP (IgAV) from testicular torsion. In testicular torsion, these studies demonstrate decreased blood flow to the testicle. In boys with HSP (IgAV), testicular blood flow is normal or increased. (See",
"    <a class=\"local\" href=\"#H10\">",
"     'Other organ involvement'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Classification criteria",
"    </span>",
"    &nbsp;&mdash;&nbsp;A variety of classification criteria for HSP (IgAV) have been proposed, primarily for use in research protocols and outcome studies. They have not been validated for the diagnosis of individual cases.",
"   </p>",
"   <p>",
"    In 1990, the American College of Rheumatology (ACR) Classification established criteria to classify seven types of vasculitides including HSP (IgAV) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40729/abstract/58,59\">",
"     58,59",
"    </a>",
"    ]. The ACR criteria for the diagnosis of HSP (IgAV) are as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Palpable purpura",
"     </li>",
"     <li>",
"      Age at onset &le;20 years",
"     </li>",
"     <li>",
"      Acute abdominal pain",
"     </li>",
"     <li>",
"      Biopsy showing granulocytes in the walls of small arterioles",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      venules",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These criteria were based upon a comparison between 85 patients with HSP (IgAV) and 722 adult patients with other forms of vasculitis. Two or more of the criteria had a sensitivity and specificity of approximately 90 percent in separating adult patients with HSP (IgAV) from those with other causes of vasculitis.",
"   </p>",
"   <p>",
"    In 2005, pediatric consensus criteria were developed by the European League against Rheumatism (EULAR) and the Paediatric Rheumatology European Society (PRES) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40729/abstract/60\">",
"     60",
"    </a>",
"    ], and were subsequently validated in conjunction with the Paediatric Rheumatology International Trials Organisation (PRINTO) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40729/abstract/61\">",
"     61",
"    </a>",
"    ]. These criteria are more appropriate for pediatric settings in which a clinician is likely seeking features to distinguish HSP (IgAV) from gastroenteritis or appendicitis rather than from granulomatosis with polyangiitis (Wegener's). The mandatory criterion is purpura (usually palpable and in clusters) or petechiae, with lower limb predominance and without thrombocytopenia or coagulopathy. Patients also must have one or more of the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Abdominal pain (usually diffuse, with acute onset)",
"     </li>",
"     <li>",
"      Arthritis or arthralgia (acute onset)",
"     </li>",
"     <li>",
"      Renal involvement (proteinuria, hematuria)",
"     </li>",
"     <li>",
"      Leukocytoclastic vasculitis or proliferative glomerulonephritis, with predominant IgA deposition",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    HSP (IgAV) is not the only disease that may have these manifestations (see",
"    <a class=\"local\" href=\"#H20\">",
"     'Differential diagnosis'",
"    </a>",
"    below). In general, HSP (IgAV) is a clinical diagnosis in children, and biopsies should be considered only rarely, in atypical or ambiguous cases.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;In children presenting with the classic signs of palpable purpura plus some combination of abdominal pain,",
"    <span class=\"nowrap\">",
"     arthritis/arthralgia,",
"    </span>",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    renal involvement, the diagnosis of HSP (IgAV) is generally straightforward [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40729/abstract/60\">",
"     60",
"    </a>",
"    ]. However, the diagnosis is more difficult if there is an incomplete presentation of HSP (IgAV) or if the skin manifestations are initially absent. In these circumstances, other causes for purpura, arthritis, abdominal pain, and renal disease need to be considered.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Purpura",
"    </span>",
"    &nbsp;&mdash;&nbsp;Petechiae and purpuric rashes may be associated with septicemia, idiopathic thrombocytopenic purpura, hemolytic uremic syndrome, leukemia, and coagulopathies (eg, hemophilia). Platelet count and coagulation studies differentiate HSP (IgAV) from these entities.",
"   </p>",
"   <p>",
"    There are several conditions that can present with purpura with normal platelet counts and coagulation studies.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Acute hemorrhagic edema of infancy (AHEI) &mdash; AHEI is a leukocytoclastic vasculitis described in children between the ages of four months to two years [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/49/40729/abstract/62-64\">",
"       62-64",
"      </a>",
"      ]. It is a self-limited disease that presents with fever, purpura, ecchymosis, and inflammatory edema of the limbs and resolves in one to three weeks (",
"      <a class=\"graphic graphic_picture graphicRef61173 \" href=\"mobipreview.htm?18/32/18945\">",
"       picture 5",
"      </a>",
"      ). Involvement of the kidney and the gastrointestinal tract is uncommon. Biopsy of the skin demonstrates a leukocytoclastic vasculitis with occasional IgA deposition. It is unclear whether this condition is truly a separate entity from HSP (IgAV), or actually overlaps with it. Case reports show renal and gastrointestinal involvement that is very similar to that of HSP (IgAV) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/49/40729/abstract/65,66\">",
"       65,66",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Hypersensitivity vasculitis &mdash; Hypersensitivity vasculitis is an inflammation of the small vessels that occurs after exposure to drugs or infection, or without an identifiable trigger [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/49/40729/abstract/59\">",
"       59",
"      </a>",
"      ]. Patients present with fever, urticaria, lymphadenopathy, and arthralgias, but not usually glomerulonephritis. Histopathology shows a leukocytoclastic vasculitis primarily of the postcapillary venules, but IgA deposition is absent. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?3/62/4070?source=see_link\">",
"       \"Hypersensitivity vasculitis in children\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Other small vessel vasculitides &mdash; There are a number of causes of small vessel vasculitis (including HSP [IgAV]) that may present with asymmetric polyneuropathy, palpable purpura,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      pulmonary-renal involvement. These diseases include primary vasculitides (eg, granulomatosis with polyangiitis (Wegener's), microscopic polyangiitis, Churg-Strauss syndrome), and vascular inflammation secondary to a connective tissue disorder (eg, systemic lupus erythematosus [SLE]) or to an infectious disease (eg, hepatitis B or C). In general, these diseases, which mimic HSP (IgAV), are uncommon in children.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Laboratory evaluation including serum complement levels, antinuclear antibodies, anti-double stranded deoxyribonuclease (anti-dsDNA), and antineutrophil cytoplasmic antibodies (ANCA), may differentiate HSP (IgAV) from the other causes of small vessel vasculitis. Light microscopic examination of a purpuric lesion will demonstrate leukocytoclasis in many small vessel vasculitides, but it is the predominance of IgA deposition that distinctively characterizes HSP (IgAV). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/42/40616?source=see_link\">",
"     \"Classification and incidence of childhood vasculitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/23/37241?source=see_link&amp;anchor=H10#H10\">",
"     \"Classification of and approach to the vasculitides in adults\", section on 'Small vessel vasculitis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Arthritis and arthralgia",
"    </span>",
"    &nbsp;&mdash;&nbsp;In about 15 percent of patients with HSP (IgAV), arthritis or arthralgia may be the presenting manifestation, usually preceding the skin manifestations by only one day. Until a patient develops the classical purpura of HSP (IgAV), other causes of joint complaints must be considered.",
"   </p>",
"   <p>",
"    Autoimmune diseases, such as systemic lupus erythematosus (SLE), juvenile idiopathic arthritis (JIA), and rheumatic fever may present with similar joint symptoms to HSP (IgAV). Assays for serum complement, antinuclear and anti-dsDNA antibodies, and rheumatoid factor may help to differentiate HSP (IgAV) from SLE and JIA, although a significant percentage of patients with HSP (IgAV) may also have transient hypocomplementemia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/49/40729/abstract/67\">",
"     67",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Evidence of a recent Group A beta-hemolytic streptococci infection (eg, anti-streptolysin O [ASLO] titers) and the clinical course distinguish acute rheumatic fever from HSP (IgAV), although it must be remembered that a significant proportion of cases of HSP (IgAV) are triggered by streptococcal infections. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/35/10810?source=see_link\">",
"     \"Systemic lupus erythematosus in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/25/24983?source=see_link\">",
"     \"Polyarticular onset juvenile idiopathic arthritis: Clinical manifestations and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/31/24056?source=see_link\">",
"     \"Pauciarticular onset juvenile idiopathic arthritis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/20/23879?source=see_link\">",
"     \"Clinical manifestations and diagnosis of acute rheumatic fever\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Septic arthritis and toxic synovitis also may present with joint symptoms similar to those seen in patients with HSP (IgAV). These typically involve only one or two joints, unlike the polyarthritis seen in HSP (IgAV). In most circumstances these conditions are easily distinguished from HSP (IgAV) by an experienced clinician. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/30/14826?source=see_link\">",
"     \"Bacterial arthritis: Clinical features and diagnosis in infants and children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Additionally, in septic arthritis, affected joints are warm and erythematous, unlike those in HSP (IgAV). Joint aspiration may be needed to differentiate the two. When considering toxic synovitis, another self-limited disease with transient joint findings that resolve without long-term sequelae, evolution of the other manifestations of HSP (IgAV) will help differentiate the two conditions. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/9/23706?source=see_link\">",
"     \"Overview of the causes of limp in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Abdominal pain",
"    </span>",
"    &nbsp;&mdash;&nbsp;Before purpura develops, distinguishing acute abdominal emergencies, such as appendicitis, from HSP (IgAV) may be very difficult. Although the rash of HSP (IgAV) usually precedes gastrointestinal manifestations, and seldom lags by more than a few days, evaluation for potential acute abdomen cannot be delayed. Serial examinations and radiologic studies are used to evaluate for surgical causes of abdominal pain. This also can include patients with HSP (IgAV) who develop gastrointestinal complications, such as intussusception, bowel infarction or perforation. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/20/11593?source=see_link\">",
"     \"Causes of acute abdominal pain in children and adolescents\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Renal disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with IgA nephropathy or Berger's disease present with immunologic and histopathologic findings similar to those of patients with HSP (IgAV). As is true of patients with HSP (IgAV), manifestations of IgA nephropathy vary from microscopic hematuria to acute renal failure. Although patients with IgA nephropathy do not have the other clinical characteristics of HSP (IgAV), these two entities might share a similar pathogenesis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/19/1337?source=see_link\">",
"     \"Clinical presentation and diagnosis of IgA nephropathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"./henoch-schonlein-purpura-iga-vasculitis-the-basics?source=see_link\">",
"       \"Patient information: Henoch-Sch&ouml;nlein purpura (IgA vasculitis) (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topic (see",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?43/22/44389?source=see_link\">",
"       \"Patient information: Vasculitis (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Henoch-Sch&ouml;nlein Purpura (HSP), also called IgA vasculitis (IgAV), is the most common systemic vasculitis of childhood. It is a self-limited disease and is characterized by a tetrad of clinical manifestations that vary in their occurrence and order of presentation. (See",
"    <a class=\"local\" href=\"#H4\">",
"     'Clinical manifestations in children'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Palpable purpura without thrombocytopenia and coagulopathy",
"     </li>",
"     <li>",
"      Arthralgia",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      arthritis",
"     </li>",
"     <li>",
"      Abdominal pain",
"     </li>",
"     <li>",
"      Renal disease",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Epidemiology and pathogenesis",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      HSP (IgAV) occurs primarily between the ages of 3 and 15 years. The annual incidence is 10 to 20 per 100,000 in children &lt;17 years of age with a peak incidence in children between four to six years of age. Approximately, 10 percent of HSP (IgAV) cases occur in adults. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The underlying cause of HSP (IgAV) is unknown. It is thought that HSP (IgAV) represents an immune-mediated vasculitis that may be triggered by a variety of antigens, including various infections or immunizations. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Pathogenesis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Diagnosis and differential diagnosis",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The diagnosis of HSP (IgAV) is usually based upon clinical manifestations of the disease. In patients with an incomplete or unusual presentation, biopsy of the affected organ (eg, skin or kidney) demonstrating predominantly IgA deposition supports the diagnosis of HSP (IgAV). (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      There are no diagnostic tests for HSP (IgAV). Patients in whom the diagnosis is at all in doubt should have a CBC, prothrombin, and urinalysis. The presence of thrombocytopenia or a coagulopathy largely excludes the diagnosis of HSP (IgAV). A serum creatinine should be obtained in children with an abnormal urinalysis. Serum creatinine should be obtained in all adult patients with HSP (IgAV) because of the increased risk of significant renal disease. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Laboratory tests'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Abdominal ultrasonography is indicated in patients with severe abdominal pain. It can detect increased bowel wall thickness, hematomas, peritoneal fluid, and intussusception. Contrast studies may miss intussusception in patients with HSP (IgAV). (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Imaging studies'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis is more difficult if there is an incomplete presentation of HSP (IgAV) or if the skin manifestations are absent at disease onset. In these circumstances, other causes for purpura, arthritis, abdominal pain, and renal disease must be considered. (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40729/abstract/1\">",
"      Jennette JC, Falk RJ, Bacon PA, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 2013; 65:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40729/abstract/2\">",
"      Gardner-Medwin JM, Dolezalova P, Cummins C, Southwood TR. Incidence of Henoch-Sch&ouml;nlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins. Lancet 2002; 360:1197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40729/abstract/3\">",
"      Yang YH, Hung CF, Hsu CR, et al. A nationwide survey on epidemiological characteristics of childhood Henoch-Sch&ouml;nlein purpura in Taiwan. Rheumatology (Oxford) 2005; 44:618.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40729/abstract/4\">",
"      Dolezalov&aacute; P, Telekesov&aacute; P, Nemcov&aacute; D, Hoza J. Incidence of vasculitis in children in the Czech Republic: 2-year prospective epidemiology survey. J Rheumatol 2004; 31:2295.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40729/abstract/5\">",
"      Blanco R, Mart&iacute;nez-Taboada VM, Rodr&iacute;guez-Valverde V, et al. Henoch-Sch&ouml;nlein purpura in adulthood and childhood: two different expressions of the same syndrome. Arthritis Rheum 1997; 40:859.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40729/abstract/6\">",
"      Bayram C, Demircin G, Erdo��an O, et al. Prevalence of MEFV gene mutations and their clinical correlations in Turkish children with Henoch-Sch&ouml;nlein purpura. Acta Paediatr 2011; 100:745.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40729/abstract/7\">",
"      Dillon MJ. Henoch-Sch&ouml;nlein purpura: recent advances. Clin Exp Rheumatol 2007; 25:S66.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40729/abstract/8\">",
"      Trapani S, Micheli A, Grisolia F, et al. Henoch Schonlein purpura in childhood: epidemiological and clinical analysis of 150 cases over a 5-year period and review of literature. Semin Arthritis Rheum 2005; 35:143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40729/abstract/9\">",
"      Calvi&ntilde;o MC, Llorca J, Garc&iacute;a-Porr&uacute;a C, et al. Henoch-Sch&ouml;nlein purpura in children from northwestern Spain: a 20-year epidemiologic and clinical study. Medicine (Baltimore) 2001; 80:279.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40729/abstract/10\">",
"      Atkinson SR, Barker DJ. Seasonal distribution of Henoch-Sch&ouml;nlein purpura. Br J Prev Soc Med 1976; 30:22.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40729/abstract/11\">",
"      Levy M, Broyer M, Arsan A, et al. Anaphylactoid purpura nephritis in childhood: natural history and immunopathology. Adv Nephrol Necker Hosp 1976; 6:183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40729/abstract/12\">",
"      Hirayama K, Kobayashi M, Kondoh M, et al. Henoch-Sch&ouml;nlein purpura nephritis associated with methicillin-resistant Staphylococcus aureus infection. Nephrol Dial Transplant 1998; 13:2703.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40729/abstract/13\">",
"      Eftychiou C, Samarkos M, Golfinopoulou S, et al. Henoch-Schonlein purpura associated with methicillin-resistant Staphylococcus aureus infection. Am J Med 2006; 119:85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40729/abstract/14\">",
"      Yang YH, Huang MT, Lin SC, et al. Increased transforming growth factor-beta (TGF-beta)-secreting T cells and IgA anti-cardiolipin antibody levels during acute stage of childhood Henoch-Sch&ouml;nlein purpura. Clin Exp Immunol 2000; 122:285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40729/abstract/15\">",
"      Trygstad CW, Stiehm ER. Elevated serum IgA globulin in anaphylactoid purpura. Pediatrics 1971; 47:1023.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40729/abstract/16\">",
"      Saulsbury FT. Alterations in the O-linked glycosylation of IgA1 in children with Henoch-Sch&ouml;nlein purpura. J Rheumatol 1997; 24:2246.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40729/abstract/17\">",
"      Saulsbury FT. Heavy and light chain composition of serum IgA and IgA rheumatoid factor in Henoch-Sch&ouml;nlein purpura. Arthritis Rheum 1992; 35:1377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40729/abstract/18\">",
"      Lau KK, Wyatt RJ, Moldoveanu Z, et al. Serum levels of galactose-deficient IgA in children with IgA nephropathy and Henoch-Sch&ouml;nlein purpura. Pediatr Nephrol 2007; 22:2067.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40729/abstract/19\">",
"      Saulsbury FT. Henoch-Sch&ouml;nlein purpura in children. Report of 100 patients and review of the literature. Medicine (Baltimore) 1999; 78:395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40729/abstract/20\">",
"      Lau KK, Suzuki H, Novak J, Wyatt RJ. Pathogenesis of Henoch-Sch&ouml;nlein purpura nephritis. Pediatr Nephrol 2010; 25:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40729/abstract/21\">",
"      Kawakami T, Watabe H, Mizoguchi M, Soma Y. Elevated serum IgA anticardiolipin antibody levels in adult Henoch-Sch&ouml;nlein purpura. Br J Dermatol 2006; 155:983.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40729/abstract/22\">",
"      Burden AD, Gibson IW, Rodger RS, Tillman DM. IgA anticardiolipin antibodies associated with Henoch-Sch&ouml;nlein purpura. J Am Acad Dermatol 1994; 31:857.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40729/abstract/23\">",
"      Yang YH, Chang CJ, Chuang YH, et al. Identification and characterization of IgA antibodies against &beta;2-glycoprotein I in childhood Henoch-Sch&ouml;nlein purpura. Br J Dermatol 2012; 167:874.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40729/abstract/24\">",
"      Jauhola O, Ronkainen J, Koskimies O, et al. Clinical course of extrarenal symptoms in Henoch-Schonlein purpura: a 6-month prospective study. Arch Dis Child 2010; 95:871.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40729/abstract/25\">",
"      Chang WL, Yang YH, Lin YT, Chiang BL. Gastrointestinal manifestations in Henoch-Sch&ouml;nlein purpura: a review of 261 patients. Acta Paediatr 2004; 93:1427.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40729/abstract/26\">",
"      Feldt RH, Stickler GB. The gastrointestinal manifestations of anaphylactoid purpura in children. Proc Staff Meet Mayo Clin 1962; 37:465.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40729/abstract/27\">",
"      Wu CS, Tung SY. Henoch-Sch&ouml;nlein purpura complicated by upper gastrointestinal bleeding with an unusual endoscopic picture. J Clin Gastroenterol 1994; 19:128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40729/abstract/28\">",
"      Nathan K, Gunasekaran TS, Berman JH. Recurrent gastrointestinal Henoch-Sch&ouml;nlein purpura. J Clin Gastroenterol 1999; 29:86.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40729/abstract/29\">",
"      Gunasekaran TS, Berman J, Gonzalez M. Duodenojejunitis: is it idiopathic or is it Henoch-Sch&ouml;nlein purpura without the purpura? J Pediatr Gastroenterol Nutr 2000; 30:22.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40729/abstract/30\">",
"      L&eacute;vy-Weil FE, Sigal M, Renard P, et al. [Acute pancreatitis in rheumatoid purpura. Apropos of 2 cases]. Rev Med Interne 1997; 18:54.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40729/abstract/31\">",
"      Cheung KM, Mok F, Lam P, Chan KH. Pancreatitis associated with Henoch-Schonlein purpura. J Paediatr Child Health 2001; 37:311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40729/abstract/32\">",
"      Amemoto K, Nagita A, Aoki S, et al. Ultrasonographic gallbladder wall thickening in children with Henoch-Schonlein purpura. J Pediatr Gastroenterol Nutr 1994; 19:126.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40729/abstract/33\">",
"      Branski D, Gross V, Gross-Kieselstein E, et al. Pancreatitis as a complication of Henoch--Schonlein purpura. J Pediatr Gastroenterol Nutr 1982; 1:275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40729/abstract/34\">",
"      Kumon Y, Hisatake K, Chikamori M, et al. A case of vasculitic cholecystitis associated with Sch&ouml;nlein-Henoch purpura in an adult. Gastroenterol Jpn 1988; 23:68.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40729/abstract/35\">",
"      Cho CS, Min JK, Park SH, et al. Protein losing enteropathy associated with Henoch-Sch&ouml;nlein purpura in a patient with rheumatoid arthritis. Scand J Rheumatol 1996; 25:334.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40729/abstract/36\">",
"      Choong CK, Beasley SW. Intra-abdominal manifestations of Henoch-Sch&ouml;nlein purpura. J Paediatr Child Health 1998; 34:405.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40729/abstract/37\">",
"      Schwab J, Benya E, Lin R, Majd K. Contrast enema in children with Henoch-Sch&ouml;nlein purpura. J Pediatr Surg 2005; 40:1221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40729/abstract/38\">",
"      Balslev T. [Schoenlein-Henoch syndrome with acute scrotal condition simulating torsion of the testis]. Ugeskr Laeger 1990; 152:678.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40729/abstract/39\">",
"      Chamberlain RS, Greenberg LW. Scrotal involvement in Henoch-Sch&ouml;nlein purpura: a case report and review of the literature. Pediatr Emerg Care 1992; 8:213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40729/abstract/40\">",
"      S&oslash;reide K. Surgical management of nonrenal genitourinary manifestations in children with Henoch-Sch&ouml;nlein purpura. J Pediatr Surg 2005; 40:1243.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40729/abstract/41\">",
"      Ha TS, Lee JS. Scrotal involvement in childhood Henoch-Sch&ouml;nlein purpura. Acta Paediatr 2007; 96:552.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40729/abstract/42\">",
"      Belman AL, Leicher CR, Mosh&eacute; SL, Mezey AP. Neurologic manifestations of Schoenlein-Henoch purpura: report of three cases and review of the literature. Pediatrics 1985; 75:687.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40729/abstract/43\">",
"      Misra AK, Biswas A, Das SK, et al. Henoch-Schonlein purpura with intracerebral haemorrhage. J Assoc Physicians India 2004; 52:833.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40729/abstract/44\">",
"      Bulun A, Topaloglu R, Duzova A, et al. Ataxia and peripheral neuropathy: rare manifestations in Henoch-Sch&ouml;nlein purpura. Pediatr Nephrol 2001; 16:1139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40729/abstract/45\">",
"      Chaussain M, de Boissieu D, Kalifa G, et al. Impairment of lung diffusion capacity in Sch&ouml;nlein-Henoch purpura. J Pediatr 1992; 121:12.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40729/abstract/46\">",
"      Nadrous HF, Yu AC, Specks U, Ryu JH. Pulmonary involvement in Henoch-Sch&ouml;nlein purpura. Mayo Clin Proc 2004; 79:1151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40729/abstract/47\">",
"      Vats KR, Vats A, Kim Y, et al. Henoch-Sch&ouml;nlein purpura and pulmonary hemorrhage: a report and literature review. Pediatr Nephrol 1999; 13:530.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40729/abstract/48\">",
"      Olson JC, Kelly KJ, Pan CG, Wortmann DW. Pulmonary disease with hemorrhage in Henoch-Sch&ouml;enlein purpura. Pediatrics 1992; 89:1177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40729/abstract/49\">",
"      Besbas N, Duzova A, Topaloglu R, et al. Pulmonary haemorrhage in a 6-year-old boy with Henoch-Sch&ouml;nlein purpura. Clin Rheumatol 2001; 20:293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40729/abstract/50\">",
"      Muqit MM, Gallagher MJ, Gavin M, et al. Henoch-Schonlein purpura with keratitis and granulomatous anterior uveitis. Br J Ophthalmol 2005; 89:1221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40729/abstract/51\">",
"      Haroon M. Should children with Henoch-Schonlein purpura and abdominal pain be treated with steroids? Arch Dis Child 2005; 90:1196.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40729/abstract/52\">",
"      Prais D, Amir J, Nussinovitch M. Recurrent Henoch-Sch&ouml;nlein purpura in children. J Clin Rheumatol 2007; 13:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40729/abstract/53\">",
"      Pillebout E, Thervet E, Hill G, et al. Henoch-Sch&ouml;nlein Purpura in adults: outcome and prognostic factors. J Am Soc Nephrol 2002; 13:1271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40729/abstract/54\">",
"      Poterucha TJ, Wetter DA, Gibson LE, et al. Histopathology and correlates of systemic disease in adult Henoch-Sch&ouml;nlein purpura: a retrospective study of microscopic and clinical findings in 68 patients at Mayo Clinic. J Am Acad Dermatol 2013; 68:420.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40729/abstract/55\">",
"      McCarthy HJ, Tizard EJ. Clinical practice: Diagnosis and management of Henoch-Sch&ouml;nlein purpura. Eur J Pediatr 2010; 169:643.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40729/abstract/56\">",
"      Jennette JC, Falk RJ. Small-vessel vasculitis. N Engl J Med 1997; 337:1512.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40729/abstract/57\">",
"      Davin JC, Ten Berge IJ, Weening JJ. What is the difference between IgA nephropathy and Henoch-Sch&ouml;nlein purpura nephritis? Kidney Int 2001; 59:823.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40729/abstract/58\">",
"      Mills JA, Michel BA, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of Henoch-Sch&ouml;nlein purpura. Arthritis Rheum 1990; 33:1114.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40729/abstract/59\">",
"      Calabrese LH, Michel BA, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of hypersensitivity vasculitis. Arthritis Rheum 1990; 33:1108.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40729/abstract/60\">",
"      Ozen S, Ruperto N, Dillon MJ, et al. EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis 2006; 65:936.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40729/abstract/61\">",
"      Ozen S, Pistorio A, Iusan SM, et al. EULAR/PRINTO/PRES criteria for Henoch-Sch&ouml;nlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria. Ann Rheum Dis 2010; 69:798.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40729/abstract/62\">",
"      Saraclar Y, Tinaztepe K, Adalio��lu G, Tuncer A. Acute hemorrhagic edema of infancy (AHEI)--a variant of Henoch-Sch&ouml;nlein purpura or a distinct clinical entity? J Allergy Clin Immunol 1990; 86:473.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40729/abstract/63\">",
"      Caksen H, Odaba�� D, K&ouml;sem M, et al. Report of eight infants with acute infantile hemorrhagic edema and review of the literature. J Dermatol 2002; 29:290.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40729/abstract/64\">",
"      Krause I, Lazarov A, Rachmel A, et al. Acute haemorrhagic oedema of infancy, a benign variant of leucocytoclastic vasculitis. Acta Paediatr 1996; 85:114.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40729/abstract/65\">",
"      Watanabe T, Sato Y. Renal involvement and hypocomplementemia in a patient with acute hemorrhagic edema of infancy. Pediatr Nephrol 2007; 22:1979.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40729/abstract/66\">",
"      Yu JE, Mancini AJ, Miller ML. Intussusception in an infant with acute hemorrhagic edema of infancy. Pediatr Dermatol 2007; 24:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/49/40729/abstract/67\">",
"      Lin Q, Min Y, Li Y, et al. Henoch-Sch&ouml;nlein purpura with hypocomplementemia. Pediatr Nephrol 2012; 27:801.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6406 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-125.39.66.147-08BE826B45-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_49_40729=[""].join("\n");
var outline_f39_49_40729=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H26\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      CLINICAL MANIFESTATIONS IN CHILDREN",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Skin manifestations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Arthritis/arthralgia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Gastrointestinal symptoms",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Intussusception",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Renal disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Other organ involvement",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H37580706\">",
"      - Scrotum",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H37580713\">",
"      - Central and peripheral nervous system",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H37580720\">",
"      - Respiratory tract",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H37580808\">",
"      - Eyes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H37580530\">",
"      Recurrent disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      CLINICAL MANIFESTATIONS IN ADULTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Biopsy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Skin",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Kidney",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Laboratory tests",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Imaging studies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Classification criteria",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Purpura",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Arthritis and arthralgia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Abdominal pain",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Renal disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Epidemiology and pathogenesis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Diagnosis and differential diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ALLRG/6406\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/6406|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?42/20/43333\" title=\"picture 1A\">",
"      Leukocytoclastic vasculitis I",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?22/37/23126\" title=\"picture 1B\">",
"      Leukocytoclastic vasculitis II",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?23/2/23599\" title=\"picture 2\">",
"      IgA nephropathy IF",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?29/6/29794\" title=\"picture 3\">",
"      Petechiae in Henoch Schonlein purpura IgA vasculitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?32/32/33282\" title=\"picture 4\">",
"      Rash - Henoch Schonlein purpura IgA vasculitis A",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?18/32/18945\" title=\"picture 5\">",
"      Hemorrhagic edema infancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/6406|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?24/8/24716\" title=\"table 1\">",
"      Findings - Henoch Schoelein purpura",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/30/14826?source=related_link\">",
"      Bacterial arthritis: Clinical features and diagnosis in infants and children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/20/11593?source=related_link\">",
"      Causes of acute abdominal pain in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/42/40616?source=related_link\">",
"      Classification and incidence of childhood vasculitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/23/37241?source=related_link\">",
"      Classification of and approach to the vasculitides in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/20/23879?source=related_link\">",
"      Clinical manifestations and diagnosis of acute rheumatic fever",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/19/1337?source=related_link\">",
"      Clinical presentation and diagnosis of IgA nephropathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/24/24968?source=related_link\">",
"      Gastrointestinal manifestations of vasculitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/62/4070?source=related_link\">",
"      Hypersensitivity vasculitis in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/20/35145?source=related_link\">",
"      Intussusception in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/62/28646?source=related_link\">",
"      Management of Henoch-Sch&ouml;nlein purpura (IgA vasculitis)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/9/23706?source=related_link\">",
"      Overview of the causes of limp in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"./henoch-schonlein-purpura-iga-vasculitis-the-basics?source=related_link\">",
"      Patient information: Henoch-Sch&ouml;nlein purpura (IgA vasculitis) (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?43/22/44389?source=related_link\">",
"      Patient information: Vasculitis (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/31/24056?source=related_link\">",
"      Pauciarticular onset juvenile idiopathic arthritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/25/24983?source=related_link\">",
"      Polyarticular onset juvenile idiopathic arthritis: Clinical manifestations and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"./renal-manifestations-of-henoch-schonlein-purpura-iga-vasculitis?source=related_link\">",
"      Renal manifestations of Henoch-Sch&ouml;nlein purpura (IgA vasculitis)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/35/10810?source=related_link\">",
"      Systemic lupus erythematosus in children",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f39_49_40730="Major histologic patterns of invasive adenocarcinoma";
var content_f39_49_40730=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F80147&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F80147&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Major histologic patterns of invasive adenocarcinoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 435px; height: 658px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A) Lepidic predominant pattern with mostly lepidic growth (right) and a smaller area of invasive acinar adenocarcinoma (left).",
"    <br>",
"     (B) Lepidic pattern consists of a proliferation type II pneumocytes and Clara cells along the surface alveolar walls.",
"     <br>",
"      (C) Area of invasive acinar adenocarcinoma (same tumor as in A and B).",
"      <br>",
"       (D) Acinar adenocarcinoma consists of round to oval-shaped malignant glands invading a fibrous stroma.",
"       <br>",
"        (E) Papillary adenocarcinoma consists of malignant cuboidal to columnar tumor cells growing on the surface of fibrovascular cores.",
"        <br>",
"         (F) Micropapillary adenocarcinoma consists of small papillary clusters of glandular cells growing within this airspace, most of which do not show fibrovascular cores.",
"         <br>",
"          (G) Solid adenocarcinoma with mucin consisting of sheets of tumor cells with abundant cytoplasm and mostly vesicular nuclei with several conspicuous nucleoli. No acinar, papillary, or lepidic patterns are seen, but multiple cells have intracytoplasmic basophilic globules that suggest intracytoplasmic mucin.",
"          <br>",
"           (H) Solid adenocarcinoma with mucin. Numerous intracytoplasmic droplets of mucin are highlighted with this diastase-periodic acid Schiff stain.",
"           <div class=\"footnotes\">",
"           </div>",
"           <div class=\"reference\">",
"            Reproduced with permission from: Travis WD, Brambilla E, Noguchi M, et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma. J Thorac Oncol 2011; 6:244. Copyright &copy; 2011 Lippincott Williams &amp; Wilkins.",
"           </div>",
"          </br>",
"         </br>",
"        </br>",
"       </br>",
"      </br>",
"     </br>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_49_40730=[""].join("\n");
var outline_f39_49_40730=null;
var title_f39_49_40731="Resp rxns during ASA chal";
var content_f39_49_40731=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F71124&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=88\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F71124&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=88\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Criteria for respiratory reactions during oral challenge with aspirin",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       ASA-induced:",
"      </td>",
"      <td class=\"subtitle1\">",
"       Events during reaction:",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Rhinitis, conjunctivitis and bronchospasm (classic reaction)",
"      </td>",
"      <td>",
"       Nasoocular reaction and &gt;15 percent decline in FEV",
"       <sub>",
"        1",
"       </sub>",
"       compared to patient's baseline",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Bronchospasm alone (lower respiratory)",
"      </td>",
"      <td>",
"       No nasoocular reaction but &gt;20 percent decline in FEV",
"       <sub>",
"        1",
"       </sub>",
"       compared to patient's baseline",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Rhinitis and conjunctivitis (upper respiratory)",
"      </td>",
"      <td>",
"       Nasoocular reactions and &lt;15 percent decline in FEV",
"       <sub>",
"        1",
"       </sub>",
"       compared to patient's baseline",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Laryngeal spasm",
"      </td>",
"      <td>",
"       Crowing sounds over trachea with an amputated inspiratory loop in the flow/volume curve",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Systemic response",
"      </td>",
"      <td>",
"       Gastrointestinal pain, flushing, urticaria, and rarely, hypotension",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Negative",
"      </td>",
"      <td>",
"       No reaction",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    Patients with AERD are usually premedicated with leukotriene modifying agents prior to challenge. In the absence of this premedication, a spectrum of reactions to aspirin challenge are observed. With premedication, the changes in FEV1 are dramatically reduced and/or eliminated, while nasal and ocular symptoms remain.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Stevenson, DD, Simon, RA, Zuraw, BL. Sensitivity to aspirin and nonsteroidal antiinflammatory drugs. In: Middleton's Allergy: Principles and Practice, 6th Ed, Adkinson, NF, Yunginger, JW, Busse, WW, et al (Eds), Mosby, St Louis, MO 2003. p.1695. Copyright &copy;2003 Elsevier.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_49_40731=[""].join("\n");
var outline_f39_49_40731=null;
var title_f39_49_40732="Herbs affecting glucose";
var content_f39_49_40732=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F59340&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F59340&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Hypoglycemic and hyperglycemic herbal ingredients",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Drug",
"       </td>",
"       <td class=\"subtitle1\">",
"        Effect",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\" rowspan=\"1\">",
"        Hypoglycemic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Alfalfa",
"       </td>",
"       <td>",
"        Hypoglycemic, manganese, human",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Aloes/Aloe vera",
"       </td>",
"       <td>",
"        Hypoglycemic, in vivo",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Burdock",
"       </td>",
"       <td>",
"        Hypoglycemic, in vivo",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Celery",
"       </td>",
"       <td>",
"        Hypoglycemic, in vivo",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Cornsilk",
"       </td>",
"       <td>",
"        Hypoglycemic, in vivo",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Damiana",
"       </td>",
"       <td>",
"        Hypoglycemic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Elecampane",
"       </td>",
"       <td>",
"        Hypoglycemic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Eucalyptus",
"       </td>",
"       <td>",
"        Hypoglycemic, in vivo",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Fenugreek",
"       </td>",
"       <td>",
"        Hypoglycemic, human",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Garlic",
"       </td>",
"       <td>",
"        Hypoglycemic, in vivo, human",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Ginger",
"       </td>",
"       <td>",
"        Hypoglycemic, in vivo",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Ginseng, Panax",
"       </td>",
"       <td>",
"        Hypoglycemic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Juniper",
"       </td>",
"       <td>",
"        Hypoglycemic, in vivo",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Marshmallow",
"       </td>",
"       <td>",
"        Hypoglycemic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Myrrh",
"       </td>",
"       <td>",
"        Hypoglycemic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Nettle",
"       </td>",
"       <td>",
"        Hypoglycemic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Sage",
"       </td>",
"       <td>",
"        Hypoglycemic, in vivo",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Tansy",
"       </td>",
"       <td>",
"        Hypoglycemic, in vivo",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\" rowspan=\"1\">",
"        Hyperglycemic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Devil's claw",
"       </td>",
"       <td>",
"        Stated to be contraindicated in diabetics",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Elecampane",
"       </td>",
"       <td>",
"        Hyperglycemic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Figwort",
"       </td>",
"       <td>",
"        Similar constituents as Devil's claw",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Ginseng, Panax",
"       </td>",
"       <td>",
"        Hyperglycemic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Hydrocotyle",
"       </td>",
"       <td>",
"        Hyperglycemic, human",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Liquorice",
"       </td>",
"       <td>",
"        Hypokalemia aggravates glucose tolerance",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted with permission from Newall CA, Anderson LA, Phillipson JD. Herbal Medicines: A Guide for Health-Care Professionals, The Pharmaceutical Press, London 1996, p.283.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_49_40732=[""].join("\n");
var outline_f39_49_40732=null;
var title_f39_49_40733="Drugs for HTV emergencies A";
var content_f39_49_40733=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F64066%7ENEPH%2F75865&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F64066%7ENEPH%2F75865&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Parenteral drugs for treatment of hypertensive emergencies*",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Drug",
"       </td>",
"       <td class=\"subtitle1\">",
"        Dose",
"       </td>",
"       <td class=\"subtitle1\">",
"        Onset of action",
"       </td>",
"       <td class=\"subtitle1\">",
"        Duration of action",
"       </td>",
"       <td class=\"subtitle1\">",
"        Adverse effects",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td class=\"subtitle1\">",
"        Special indications",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"6\">",
"        Vasodilators",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Sodium nitroprusside",
"       </td>",
"       <td>",
"        0.25-10 &micro;g/kg/min as IV infusion",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        Immediate",
"       </td>",
"       <td>",
"        1-2 min",
"       </td>",
"       <td>",
"        Nausea, vomiting, muscle twitching, sweating, thiocynate and cyanide intoxication",
"       </td>",
"       <td>",
"        Most hypertensive emergencies; caution with high intracranial pressure or azotemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Nicardipine hydrochloride",
"       </td>",
"       <td>",
"        5-15 mg/h IV",
"       </td>",
"       <td>",
"        5-10 min",
"       </td>",
"       <td>",
"        15-30 min, may exceed 4 h",
"       </td>",
"       <td>",
"        Tachycardia, headache, flushing, local phlebitis",
"       </td>",
"       <td>",
"        Most hypertensive emergencies except acute heart failure; caution with coronary ischemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Clevidipine",
"       </td>",
"       <td>",
"        1-2 mg/h IV with rapid titration to max of 16 mg/h",
"       </td>",
"       <td>",
"        1-2 min",
"       </td>",
"       <td>",
"        5-15 min",
"       </td>",
"       <td>",
"        Atrial fibrillation, nausea",
"       </td>",
"       <td>",
"        All hypertensive emergencies",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Fenoldopam mesylate",
"       </td>",
"       <td>",
"        0.1-0.3 &micro;g/kg per min IV infusion",
"       </td>",
"       <td>",
"        &lt;5 min",
"       </td>",
"       <td>",
"        30 min",
"       </td>",
"       <td>",
"        Tachycardia, headache, nausea, flushing",
"       </td>",
"       <td>",
"        Most hypertensive emergencies; caution with glaucoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Nitroglycerin",
"       </td>",
"       <td>",
"        5-100 &micro;g/min as IV infusion",
"       </td>",
"       <td>",
"        2-5 min",
"       </td>",
"       <td>",
"        5-10 min",
"       </td>",
"       <td>",
"        Headache, vomiting, methemoglobinemia, tolerance with prolonged use",
"       </td>",
"       <td>",
"        Coronary ischemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Enalaprilat",
"       </td>",
"       <td>",
"        1.25-5 mg every 6 h IV",
"       </td>",
"       <td>",
"        15-30 min",
"       </td>",
"       <td>",
"        6-12 h",
"       </td>",
"       <td>",
"        Precipitous fall in pressure in high-renin states; variable response",
"       </td>",
"       <td>",
"        Acute left ventricular failure; avoid in acute myocardial infarction",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" rowspan=\"2\">",
"        Hydralazine hydrochloride",
"       </td>",
"       <td>",
"        10-20 mg IV",
"       </td>",
"       <td>",
"        10-20 min IV",
"       </td>",
"       <td>",
"        1-4 h IV",
"       </td>",
"       <td rowspan=\"2\">",
"        Tachycardia, flushing, headache, vomiting, aggravation of angina",
"       </td>",
"       <td rowspan=\"2\">",
"        Eclampsia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        10-40 mg IM",
"       </td>",
"       <td>",
"        20-30 min IM",
"       </td>",
"       <td>",
"        4-6 h IM",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * These doses may vary from those in the Physicians' Desk Reference (64th edition).",
"     <br>",
"      <span class=\"bullet\">",
"       &bull;",
"      </span>",
"      Hypotension may occur with all agents.",
"      <br>",
"       &Delta; Requires special delivery system.",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Adapted with permission from: Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003; 42:1206. Copyright &copy; 2003 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Parenteral drugs for treatment of hypertensive emergencies, continued*",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Drug",
"       </td>",
"       <td class=\"subtitle1\">",
"        Dose",
"       </td>",
"       <td class=\"subtitle1\">",
"        Onset of action",
"       </td>",
"       <td class=\"subtitle1\">",
"        Duration of action",
"       </td>",
"       <td class=\"subtitle1\">",
"        Adverse effects",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td class=\"subtitle1\">",
"        Special indications",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"6\">",
"        Andrenergic inhibitors",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" rowspan=\"2\">",
"        Labetalol hydrochloride",
"       </td>",
"       <td>",
"        20-80 mg IV bolus every 10 min",
"       </td>",
"       <td rowspan=\"2\">",
"        5-10 min",
"       </td>",
"       <td rowspan=\"2\">",
"        3-6 h",
"       </td>",
"       <td rowspan=\"2\">",
"        Vomiting, scalp tingling, bronchoconstriction, dizziness, nausea, heart block, orthostatic hypotension",
"       </td>",
"       <td rowspan=\"2\">",
"        Most hypertensive emergencies except acute heart failure",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        0.5-2.0 mg/min IV infusion",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Esmolol hydrochloride",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        250-500 &micro;g/kg/min by infusion; may repeat bolus after 5 min or increase infusion to 300 &micro;g/min",
"       </td>",
"       <td>",
"        1-2 min",
"       </td>",
"       <td>",
"        10-30 min",
"       </td>",
"       <td>",
"        Hypotension, nausea, asthma, first-degree heart block, HF",
"       </td>",
"       <td>",
"        Aortic dissection, perioperative",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Phentolamine",
"       </td>",
"       <td>",
"        5-15 mg IV bolus",
"       </td>",
"       <td>",
"        1-2 min",
"       </td>",
"       <td>",
"        10-30 min",
"       </td>",
"       <td>",
"        Tachycardia, flushing, headache",
"       </td>",
"       <td>",
"        Catecholamine excess",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * These doses may vary from those in the Physicians' Desk Reference (64th edition).",
"     <br>",
"      <span class=\"bullet\">",
"       &bull;",
"      </span>",
"      Hypotension may occur with all agents.",
"      <br>",
"       &Delta; Requires special delivery system.",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Adapted with permission from: Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003; 42:1206. Copyright &copy; 2003 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_49_40733=[""].join("\n");
var outline_f39_49_40733=null;
var title_f39_49_40734="Ewings sarcoma left tibia";
var content_f39_49_40734=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F62643&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F62643&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Ewing sarcoma in the left tibia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 198px; height: 519px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Plain radiograph of a Ewing sarcoma of the distal left tibia in a nine year old girl, demonstrating extensive cortical destruction.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Thomas DeLaney, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_49_40734=[""].join("\n");
var outline_f39_49_40734=null;
var title_f39_49_40735="Common locations of common enlarged parathyroid glands";
var content_f39_49_40735=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F87046&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F87046&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Common locations of common enlarged parathyroid glands",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 314px; height: 518px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_49_40735=[""].join("\n");
var outline_f39_49_40735=null;
